Data / Research funding / Heart Disease
Heart Disease: 6,066 NIH awards ($8.1B) to 644 organizations
6,066 NIH awards ($8.1B) in the NIH spending category Heart Disease, to 644 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 6,066 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| NHLBI Community Engagement Technical Assistance Center (CETAC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $367,122,105 | September 25, 2020 | August 31, 2026 | BAYTOP, CHANZA | reporter.nih.gov |
| Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT) | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $39,483,481 | September 18, 2018 | July 31, 2028 | LAM, WILBUR A | reporter.nih.gov |
| Network for Cardiothoracic Surgical Investigations in Cardiovascular Medicine | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $39,139,386 | July 1, 2007 | February 28, 2027 | GELIJNS, ANNE CHRISTINE | reporter.nih.gov |
| Epidemiology of Diabetes Interventions and Complications (EDIC) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $35,015,476 | September 22, 2011 | June 30, 2027 | GUBITOSI-KLUG, ROSE A | reporter.nih.gov |
| Physical Rehabilitation for Older Patients with Acute HFpEF-The REHAB-HFpEF Trial | NIH | National Institute on Aging | 2022 to 2025 | $26,596,811 | August 15, 2022 | July 31, 2028 | KITZMAN, DALANE W | reporter.nih.gov |
| Ola HAWAII | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $25,522,287 | September 23, 1997 | May 31, 2027 | HEDGES, JERRIS ROBERT | reporter.nih.gov |
| Center for Chronic Disease Reduction and Equity Promotion Across Minnesota (C2DREAM) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $24,809,662 | September 24, 2021 | December 31, 2026 | ALLEN, MICHELE L | reporter.nih.gov |
| The Mid-Atlantic Center for Cardiometabolic Health (MACCH) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $24,163,298 | September 24, 2021 | June 30, 2027 | COOPER, LISA A | reporter.nih.gov |
| Administrative Coordinating Center: Bench to Bassinet Program | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $21,378,391 | January 1, 2016 | December 31, 2025 | OLLBERDING, NICHOLAS J | reporter.nih.gov |
| RURAL: Risk Underlying Rural Areas Longitudinal Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $21,300,494 | May 15, 2019 | April 30, 2026 | RAMACHANDRAN, VASAN | reporter.nih.gov |
| Study of Latinos-Investigation of Neurocognitive Aging-Alzheimer's disease | NIH | National Institute on Aging | 2022 to 2025 | $17,997,906 | May 15, 2022 | January 31, 2028 | GONZALEZ, HECTOR M | reporter.nih.gov |
| The Heart and the Mind: An Integrative Approach to Brain-Body Interactions in the Zebrafish | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $17,898,597 | September 25, 2017 | August 31, 2027 | ENGERT, FLORIAN | reporter.nih.gov |
| Continuation of the NuMoM2b Heart Health Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $17,402,772 | February 15, 2020 | January 31, 2027 | MCNEIL, REBECCA BOEHM | reporter.nih.gov |
| HeartShare DeCODE-HF: Data translation center to Combine Omics, Deep phenotyping, and Electronic health records for Heart Failure subtypes and treatment targets | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $16,979,349 | September 13, 2021 | December 31, 2027 | SHAH, SANJIV J | reporter.nih.gov |
| 1/2 Pediatric Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $16,489,352 | September 15, 2021 | August 31, 2028 | MOLER, FRANK W | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE - CLINICAL COORDINATING CENTER: TASK AREA B - LONG LIFE STUDY VISIT 2 LIMITED HOME VISIT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $15,096,788 | March 4, 2022 | March 3, 2024 | ANDERSON, GARNET | reporter.nih.gov |
| Data Coordinating Center for the Pediatric Heart Network | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $15,075,464 | July 1, 2017 | December 31, 2024 | MILLER, JULIE ELAINE | reporter.nih.gov |
| HISPANIC COMMUNITY HEALTH STUDY-STUDY OF LATINOS (HCHS-SOL)- COORDINATING CENTER | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $15,035,695 | November 30, 2018 | November 29, 2024 | CAI, JIANWEN | reporter.nih.gov |
| The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $14,978,926 | August 25, 2022 | July 31, 2029 | PASSMAN, ROD S | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) FIELD CENTER (FC) - TASK AREA D | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $14,739,138 | August 13, 2023 | August 12, 2025 | CARSON, APRIL | reporter.nih.gov |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), COORDINATING CENTER - TASK AREA A - CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,440,476 | December 19, 2024 | April 11, 2025 | MCCLELLAND, ROBYN LEAGH | reporter.nih.gov |
| 1/2 REPRIEVE Extension for Trial Completion | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $14,219,228 | May 1, 2023 | April 30, 2027 | GRINSPOON, STEVEN K. | reporter.nih.gov |
| Vanderbilt Memory & Aging Project | NIH | National Institute on Aging | 2021 to 2025 | $14,019,775 | March 15, 2011 | March 31, 2027 | JEFFERSON, ANGELA L. | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) COORDINATING CENTER (CC) - TASK AREA D | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $13,919,988 | August 13, 2023 | August 12, 2025 | CARSON, APRIL | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - COORDINATING CENTER - TASK AREA B.2 AND B.3 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $13,712,636 | November 15, 2024 | September 30, 2025 | COUPER, DAVID | reporter.nih.gov |
| 1/2 ICECAP: Influence of Cooling duration on Efficacy in Cardiac Arrest Patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $13,466,840 | September 19, 2019 | August 31, 2025 | MEURER, WILLIAM JOSEPH | reporter.nih.gov |
| Integrating lifecourse approaches, biologic and digital phenotypes in support of heart and lung disease epidemiologic research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,991,264 | February 8, 2019 | January 31, 2027 | CHAVARRO, JORGE EDUARDO | reporter.nih.gov |
| Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | NIH | National Institute on Aging | 2022 to 2025 | $12,690,286 | April 15, 2017 | April 30, 2027 | KAPLAN, HILLARD S | reporter.nih.gov |
| STRONG HEART STUDY (SHS)- COORDINATING CENTER (CC)- TASK ORDER 001 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $11,834,846 | February 15, 2019 | February 14, 2026 | ZHANG, YING | reporter.nih.gov |
| Metabolic Basis of Disease - Phase 2 | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,560,620 | March 1, 2020 | July 31, 2030 | STEPHENS, JACQUELINE M | reporter.nih.gov |
| Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $10,486,985 | September 1, 2014 | August 31, 2026 | TITA, ALAN THEVENET N. | reporter.nih.gov |
| Vermont Center for Cardiovascular and Brain Health | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $10,185,844 | August 6, 2020 | May 31, 2026 | CUSHMAN, MARY | reporter.nih.gov |
| The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial EXTENDed Follow-up (EXTEND) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $10,079,314 | April 1, 2021 | March 31, 2027 | HOCHMAN, JUDITH S | reporter.nih.gov |
| Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,739,425 | September 1, 2022 | April 30, 2027 | GLADWIN, MARK T | reporter.nih.gov |
| The Fragile Families Cardiovascular Health Follow Up Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $9,555,568 | August 1, 2020 | July 31, 2025 | NOTTERMAN, DANIEL A. | reporter.nih.gov |
| Immune Cell Interactions in Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,386,571 | August 1, 2017 | May 31, 2027 | HEDRICK, CATHERINE C | reporter.nih.gov |
| The San Antonio Heart and Mind Study | NIH | National Institute on Aging | 2023 to 2025 | $9,286,743 | July 1, 2023 | March 31, 2029 | SATIZABAL, CLAUDIA L | reporter.nih.gov |
| Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $9,111,057 | July 1, 2019 | April 30, 2027 | SHETH, KEVIN NAVIN | reporter.nih.gov |
| Center for Stress and Neural Regulation of Reproductive Aging Health Outcomes | NIH | National Institute on Aging | 2021 to 2025 | $8,986,759 | June 1, 2020 | August 31, 2030 | JOFFE, HADINE | reporter.nih.gov |
| RURAL: Risk Underlying Rural Areas Longitudinal Cohort Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $8,923,910 | May 15, 2019 | April 30, 2025 | RAMACHANDRAN, VASAN S | reporter.nih.gov |
| FRAMINGHAM HEART STUDY (FHS), TASK AREA A - CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2025 | $8,894,939 | February 14, 2025 | February 13, 2026 | LLOYD-JONES, DONALD | reporter.nih.gov |
| Coronary Artery Calcium and its Association with Protective/Risk Factors and Epigenetic Patterns in Diverse US Hispanic/Latino Adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $8,752,600 | June 1, 2021 | May 31, 2026 | DAVIGLUS, MARTHA L | reporter.nih.gov |
| Stanford Center for Connecting DNA Variants to Function and Phenotype | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,717,486 | September 3, 2021 | May 31, 2026 | ENGREITZ, JESSE M | reporter.nih.gov |
| Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,671,281 | September 1, 2021 | May 31, 2027 | PINELLO, LUCA | reporter.nih.gov |
| Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $8,561,222 | September 10, 2021 | August 31, 2026 | FREIBERG, MATTHEW S | reporter.nih.gov |
| REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-4 (REGARDS-MI-4) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $8,345,645 | September 10, 2022 | July 31, 2027 | SAFFORD, MONIKA M | reporter.nih.gov |
| Data-Driven Sleep Biomarkers of Brain Health, Heart Health, and Mortality | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $8,267,463 | September 1, 2022 | August 31, 2026 | THOMAS, ROBERT JOSEPH | reporter.nih.gov |
| Systematically mapping variant effects for cardiovascular genes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $8,116,228 | August 25, 2022 | June 30, 2026 | RODEN, DAN M | reporter.nih.gov |
| Sex Differences in Major Depression: Impact of Prenatal Stress-Immune and Autonomic Dysregulation | NIH | National Institute of Mental Health | 2021 to 2024 | $7,968,668 | February 1, 2020 | April 24, 2025 | GOLDSTEIN, JILL M | reporter.nih.gov |
| Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $7,961,623 | September 30, 2020 | August 31, 2025 | SCHECHTMAN, KENNETH B. | reporter.nih.gov |
| RACE-CARS CCC 1/2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,922,259 | July 1, 2020 | June 30, 2027 | GRANGER, CHRISTOPHER B. | reporter.nih.gov |
| Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,505,536 | September 1, 2021 | July 31, 2027 | DAUBERT, MELISSA | reporter.nih.gov |
| Biogenesis and Catabolism of Atherogenic Lipoproteins | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $7,418,574 | May 1, 2023 | April 30, 2028 | HUSSAIN, M MAHMOOD | reporter.nih.gov |
| Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $7,354,954 | May 15, 2023 | April 30, 2028 | COLECRAFT, HENRY M. | reporter.nih.gov |
| Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS II) | NIH | National Institute on Aging | 2024 to 2025 | $7,286,036 | June 15, 2024 | November 30, 2029 | JOHNSON-AKEJU, OLUWASEUN | reporter.nih.gov |
| Diabetes Research and Training Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,258,898 | December 1, 1996 | March 31, 2028 | MIRMIRA, RAGHAVENDRA G | reporter.nih.gov |
| Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $7,099,019 | August 1, 2022 | May 31, 2027 | ATKINSON, MARK A. | reporter.nih.gov |
| PREcision Care In Cardiac ArrEst - ICECAP (PRECICECAP) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $7,046,260 | December 15, 2020 | April 30, 2026 | HIRSCH, KAREN G | reporter.nih.gov |
| Exosomes as mediators of cardiac injury and repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,022,243 | September 1, 2017 | June 30, 2029 | KISHORE, RAJ | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,882,445 | September 29, 2025 | September 28, 2026 | WACTAWSKI-WENDE, JEAN | reporter.nih.gov |
| CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - COORDINATING CENTER (CC) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $6,837,690 | July 1, 2024 | June 30, 2025 | LI, JING | reporter.nih.gov |
| Implementing and Personalizing Best-In-Class Opioid-sparing Pain Management for Major Inpatient Surgeries in Children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $6,720,269 | September 5, 2024 | August 31, 2029 | SADHASIVAM, SENTHILKUMAR | reporter.nih.gov |
| 1/2, Clinical Coordinating Center for the Long-term Effectiveness of the Anti-obesity medication Phentermine: the LEAP Trial | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,684,343 | September 17, 2021 | August 31, 2027 | LEWIS, KRISTINA H | reporter.nih.gov |
| Cavopulmonary Assist to Reverse the Fontan | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,543,627 | September 14, 2020 | August 31, 2025 | RODEFELD, MARK D | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,534,889 | September 29, 2025 | September 28, 2026 | STEFANICK, MARCIA | reporter.nih.gov |
| Polygenic Risk Scores for Diverse Populations - Bridging Research and Clinical Care | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,401,936 | August 20, 2020 | July 31, 2025 | KOOPERBERG, CHARLES L | reporter.nih.gov |
| Objective Physical Activity and Cardiovascular Health in Older Women: OPACH2 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,198,164 | August 15, 2022 | June 30, 2027 | LACROIX, ANDREA Z. | reporter.nih.gov |
| IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related Dementia | NIH | National Institute on Aging | 2021 to 2023 | $6,168,197 | April 15, 2020 | March 31, 2024 | HAY, MEREDITH | reporter.nih.gov |
| Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients (PANDORA) - Administrative Supplement | NIH | National Institute on Aging | 2021 to 2025 | $6,139,069 | September 30, 2019 | November 30, 2026 | SUBRAMANIAM, BALACHUNDHAR | reporter.nih.gov |
| PET/MRI imaging of mitral valve prolapse | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $6,137,934 | August 25, 2023 | June 30, 2028 | TRIVIERI, MARIA GIOVANNA | reporter.nih.gov |
| Metabolic effects and mechanisms for heart failure in South Asians | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,092,913 | June 7, 2021 | May 31, 2027 | KANAYA, ALKA M. | reporter.nih.gov |
| Development of the Inspired Therapeutics NeoMate Mechanical Circulatory Support System for Neonates and Infants | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,070,246 | July 1, 2018 | June 30, 2027 | TAMEZ, DANIEL | reporter.nih.gov |
| 2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,043,000 | August 25, 2022 | July 31, 2029 | HANLEY, DANIEL F | reporter.nih.gov |
| Hypertrophic Cardiomyopathy: Understanding the Heterogeneity of Disease Expression and Outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $5,898,403 | September 1, 2021 | August 31, 2025 | HO, CAROLYN Y | reporter.nih.gov |
| Phase IA/IB Study of AAVrh.10hFXN Therapy to Treat the Cardiomyopathy of Friedreich's Ataxia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $5,884,638 | August 1, 2020 | August 31, 2025 | CRYSTAL, RONALD G | reporter.nih.gov |
| STRONG HEART STUDY (SHS)- FIELD CENTER, TASK ORDER 001 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,867,487 | February 15, 2019 | February 14, 2026 | FRETTS, AMANDA MAE | reporter.nih.gov |
| Improving Diagnostic Accuracy for Acute Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $5,861,300 | May 15, 2021 | April 30, 2026 | GUPTA, DEEPAK | reporter.nih.gov |
| Cardiovascular Development Data Resource Center (CDDRC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $5,768,733 | August 20, 2020 | July 31, 2025 | YOST, H. JOSEPH | reporter.nih.gov |
| Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease | NIH | National Institute on Drug Abuse | 2021 to 2024 | $5,744,264 | June 1, 2016 | April 30, 2025 | LAI, SHENGHAN | reporter.nih.gov |
| Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,660,048 | March 1, 2023 | February 29, 2028 | BRICKMAN, WENDY J | reporter.nih.gov |
| A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti - 2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,606,044 | August 1, 2018 | June 30, 2028 | MCNAIRY, MARGARET LEIGHTON | reporter.nih.gov |
| Interplay of Myocardial Fibrosis and Cardiac TTR Amyloid in Age Related Cardiac Remodeling in MESA-Multi-Ethnic Study of Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,552,808 | April 1, 2022 | March 31, 2027 | LIMA, JOAO A C | reporter.nih.gov |
| Late-life trajectories of cardiac function to define pathways of cardiac resilience | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,538,517 | July 1, 2017 | May 31, 2027 | SHAH, AMIL M | reporter.nih.gov |
| Trial to Assess Chelation Therapy 2 (TACT2) DCC Competing Renewal | NIH | National Center for Complementary & Integrative Health | 2022 to 2024 | $5,394,975 | September 30, 2015 | July 31, 2025 | MARK, DANIEL B | reporter.nih.gov |
| Physical Activity to Improve CV Health in Older Women: A Pragmatic Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $5,255,718 | September 15, 2020 | August 31, 2025 | KOOPERBERG, CHARLES L | reporter.nih.gov |
| Biomechanical Optimization of Mitral Valve Repair Operations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,222,284 | May 5, 2020 | August 31, 2029 | WOO, Y JOSEPH | reporter.nih.gov |
| Nebraska Center for Heart and Vascular Research | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $5,207,382 | January 1, 2024 | December 31, 2028 | GUNDRY, REBEKAH L. | reporter.nih.gov |
| Vascular Determinants of Stage B HF among Hispanics: the role of the Heart-Vascular Interaction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,202,727 | September 1, 2022 | August 31, 2027 | RODRIGUEZ, CARLOS JOSE | reporter.nih.gov |
| Safety and efficacy of Belatacept in heart transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,158,955 | June 6, 2023 | March 31, 2028 | HABAL, MARLENA | reporter.nih.gov |
| Decrypting Variants of Uncertain Significance in Long-QT Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $5,148,685 | August 1, 2014 | July 31, 2026 | GEORGE, ALFRED L. | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) UNDERGRADUATE TRAINING AND EDUCATION CENTER (UTEC) - TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $5,146,731 | August 13, 2023 | August 12, 2025 | WHITE, WENDY | reporter.nih.gov |
| Trisomy 21 and its impact on hedgehog-dependent gene regulation and differentiation timing | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $5,112,898 | September 1, 2024 | March 31, 2026 | MOSKOWITZ, IVAN PAUL | reporter.nih.gov |
| Identifying new strategies for prevention of cardiovascular complications of diabetes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,112,534 | May 1, 2020 | April 30, 2026 | BORNFELDT, KARIN E | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER, TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,086,390 | November 15, 2021 | March 14, 2026 | LUTSEY, PAMELA L. | reporter.nih.gov |
| Research Resource for Complex Physiologic Signals | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $5,085,077 | September 1, 2007 | June 30, 2028 | GOLDBERGER, ARY LOUIS | reporter.nih.gov |
| Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,079,600 | March 6, 2019 | February 28, 2026 | KNOLLMANN, BJORN C | reporter.nih.gov |
| Study of Latinos Investigation of Neurocognitive Aging 2 | NIH | National Institute on Aging | 2021 | $5,055,467 | September 1, 2015 | April 30, 2023 | GONZALEZ, HECTOR M | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,000,825 | September 29, 2025 | September 28, 2026 | JACKSON, REBECCA | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER, TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,994,412 | November 15, 2021 | February 19, 2026 | WAGENKNECHT, LYNNE E | reporter.nih.gov |
| STRONG HEART STUDY (SHS)- FIELD CENTER (FC)- TASK ORDER 001 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,926,901 | February 15, 2019 | February 14, 2026 | ALI, TAUQEER | reporter.nih.gov |
| Patterns of Survivors' Recovery Trajectories in the ICECAP Trial (POST-ICECAP) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $4,873,622 | June 1, 2023 | May 31, 2028 | AGARWAL, SACHIN | reporter.nih.gov |
| IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,866,733 | July 1, 2022 | June 30, 2027 | ERICKSON, LOREN D | reporter.nih.gov |
| Epidemiologic Determinants of Cardiac Structure and Function in Rural Residents: RURAL ECHO | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,861,063 | February 21, 2022 | December 31, 2026 | BLOOMFIELD, GERALD SAMUEL | reporter.nih.gov |
| Targeted DOK7 gene therapy for Congenital Myasthenic Syndromes | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,856,116 | September 15, 2021 | August 31, 2026 | SEPULVEDA, PATRICIO | reporter.nih.gov |
| Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,830,116 | June 1, 2020 | May 31, 2027 | DAS, SAUMYA | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER, TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,813,353 | January 15, 2025 | January 14, 2026 | WINDHAM, BEVERLY GWEN | reporter.nih.gov |
| Pathophysiology of Myocardial Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,786,349 | July 1, 1981 | June 30, 2026 | POST, WENDY S | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,714,816 | January 1, 2025 | December 31, 2025 | ARGANI, PEDRAM | reporter.nih.gov |
| Emory Specialized Center of Research Excellence (SCORE) on Sex Differences | NIH | National Institute on Aging | 2021 to 2025 | $4,701,718 | September 30, 2018 | July 31, 2030 | LAHIRI, CECILE DELILLE | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) GRADUATE TRAINING AND EDUCATION CENTER (GTEC) - TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,701,181 | August 13, 2023 | August 12, 2025 | PAYTON, MARINELLE | reporter.nih.gov |
| Noninvasive measurement of oxygenation using quantitative susceptibility mapping | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,679,068 | January 1, 2021 | December 31, 2026 | SPINCEMAILLE, PASCAL | reporter.nih.gov |
| Multi-functional anti-thrombotic therapy for coronary microvascular obstruction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $4,660,810 | May 1, 2023 | April 30, 2027 | CHEN, RIDONG | reporter.nih.gov |
| Toward efficient performance for deep learning on medical imaging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,624,228 | April 1, 2020 | March 31, 2030 | ARNAOUT, RIMA | reporter.nih.gov |
| Altering Cardiac Cell Fate for Heart Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,621,749 | January 13, 2021 | November 30, 2027 | QIAN, LI | reporter.nih.gov |
| IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,621,686 | July 1, 1984 | May 31, 2028 | PLATTS-MILLS, THOMAS A. | reporter.nih.gov |
| Endogenous circadian mechanisms underlying cardiovascular risk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,596,491 | July 1, 2021 | June 30, 2028 | SHEA, STEVEN A | reporter.nih.gov |
| Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $4,589,716 | September 1, 2019 | August 31, 2024 | KIZER, JORGE R | reporter.nih.gov |
| The Heart Outcomes for Pregnancy Expectations Study | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $4,577,952 | September 20, 2024 | May 31, 2028 | SPERTUS, JOHN A | reporter.nih.gov |
| The CHARMED model: a multimorbidity simulation model for people aging with HIV | NIH | National Institute on Aging | 2021 to 2025 | $4,557,763 | April 1, 2021 | March 31, 2027 | HYLE, EMILY PARKER | reporter.nih.gov |
| PRE-DETERMINE: Advancing Sudden Arrhythmic Death Prediction in Coronary Artery Disease in the Absence of Severe Systolic Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $4,550,671 | February 15, 2023 | January 31, 2027 | ALBERT, CHRISTINE M | reporter.nih.gov |
| Role of the giant protein titin in cardiac health and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,512,900 | April 1, 2019 | March 31, 2026 | GRANZIER, HENK L. | reporter.nih.gov |
| Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,466,979 | May 1, 2018 | April 30, 2025 | MADSEN, JOREN C | reporter.nih.gov |
| Contemporary Classification of Myocardial Injury Events in MESA: Defining Distinct Risk Factor Associations with Myocardial Infarction Type 1-5 and Acute Non-Ischemic Myocardial Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,444,163 | August 20, 2021 | July 31, 2027 | DEFILIPPIS, ANDREW | reporter.nih.gov |
| Mechanisms addressing the causal relationships of sleep, circadian rhythms, and cardiometabolic health | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,415,189 | June 1, 2021 | May 31, 2028 | ST-ONGE, MARIE-PIERRE | reporter.nih.gov |
| The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $4,414,294 | September 29, 2009 | December 31, 2026 | MANSON, JOANN ELISABETH | reporter.nih.gov |
| Cognitive Impairment and Dementia, Vascular Brain Injury, and Atrial Myopathy: Implications for Prevention of Alzheimer's Disease-Related Dementias | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $4,390,219 | September 20, 2023 | August 31, 2026 | CHEN, LIN YEE | reporter.nih.gov |
| Leveraging multi-omics approaches to examine metabolic challenges of obesity in relation to cardiovascular diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $4,370,219 | April 1, 2019 | March 31, 2025 | GORDON-LARSEN, PENNY | reporter.nih.gov |
| Elucidating Mechanism of Cardiac Fibrosis with Cell Village of Pooled Human iPSCs | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,345,357 | December 16, 2015 | May 31, 2028 | WU, JOSEPH C. | reporter.nih.gov |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK AREA A - CORE OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,339,742 | December 19, 2024 | April 11, 2025 | WATSON, KAROL E | reporter.nih.gov |
| Multimodality Deep Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $4,336,438 | September 15, 2023 | June 30, 2028 | VERNINO, STEVEN A | reporter.nih.gov |
| SCAN-MP (Screening for Cardiac Amyloidosiswith Nuclear imaging in Minority Populations) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,328,776 | May 1, 2019 | February 28, 2025 | MAURER, MATHEW S | reporter.nih.gov |
| Serotonin Signaling in Mitral Valve Homeostasis, Maintenance and Restoration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,327,587 | April 1, 2016 | May 31, 2029 | LEVY, ROBERT J | reporter.nih.gov |
| Renewing the heart: cardiomyocyte cell cycle regulation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,326,704 | March 15, 2019 | February 28, 2026 | EVANS, SYLVIA M | reporter.nih.gov |
| Single cell, whole genome analysis of the aging human cardiomyocyte | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,321,874 | January 15, 2021 | December 31, 2025 | CHOUDHURY, SANGITA | reporter.nih.gov |
| Proteomic Profiling of Precise Exercise Pathophenotypes Across the HFpEF Spectrum | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $4,277,441 | January 1, 2016 | February 28, 2027 | NAYOR, MATTHEW G. | reporter.nih.gov |
| Mechanisms of Platelet Activity in Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,269,155 | February 15, 2019 | January 31, 2027 | BERGER, JEFFREY S | reporter.nih.gov |
| Cardiorenal Genomics for Risk Prediction in African Descent Populations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,261,183 | September 1, 2021 | August 31, 2028 | IRVIN, MARGUERITE R | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,249,024 | September 29, 2025 | September 28, 2026 | VITOLINS, MARA | reporter.nih.gov |
| Combined Cardiopulmonary Failure in COPD: SPIROMICS HF | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $4,223,234 | August 28, 2008 | June 30, 2025 | BARR, R GRAHAM | reporter.nih.gov |
| Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $4,182,561 | May 1, 2024 | August 31, 2025 | ESBENSEN, ANNA J. | reporter.nih.gov |
| Cognitive Aging, Brain Morphology, and Arrhythmias in Hispanics/Latinos: Implications for Prevention and Management of Alzheimer's Disease-Related Dementias | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $4,131,388 | April 1, 2022 | March 31, 2025 | CHEN, LIN YEE | reporter.nih.gov |
| AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $4,101,394 | May 1, 2017 | April 30, 2025 | MARSHALL, RANDOLPH S | reporter.nih.gov |
| Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,067,768 | May 1, 2021 | April 30, 2027 | BALKO, JUSTIN M | reporter.nih.gov |
| Low-Profile 3D-Printed Radiopaque Bioresorbable Vascular Scaffolds | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,062,443 | January 1, 2019 | April 30, 2028 | AMEER, GUILLERMO ANTONIO | reporter.nih.gov |
| Myocardial Radiomics and Mechanics in the Pathology and Prognosis of Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,060,359 | March 15, 2021 | February 28, 2027 | TSAO, CONNIE | reporter.nih.gov |
| Probing Phenotype-Genotype Relations After Whole Genome Sequencing in Patients with Atrial Fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,058,145 | September 1, 2021 | July 31, 2026 | SHOEMAKER, MOORE BENJAMIN | reporter.nih.gov |
| Diagnosis, Prevention, And Treatment Of Cardiovascular Diseases With Genome Editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,046,250 | March 20, 2019 | February 28, 2026 | MUSUNURU, KIRAN | reporter.nih.gov |
| Patient-specific Outcome Prediction from Cardiovascular Multimodality Imaging by Artificial Intelligence | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,034,369 | June 1, 2022 | May 31, 2029 | SLOMKA, PIOTR J | reporter.nih.gov |
| Immune checkpoint inhibitors and accelerated coronary atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,014,114 | May 1, 2022 | April 30, 2027 | NEILAN, TOMAS G | reporter.nih.gov |
| STRONG HEART STUDY (SHS) - FIELD CENTER, TASK ORDER 001, BASE PERIOD, FEBRUARY 15, 2019 TO FEBRUARY 14, 2020 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,009,277 | February 15, 2019 | February 14, 2026 | UMANS, JASON G | reporter.nih.gov |
| Engineered Stem Cells for Cardiac Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,984,462 | February 1, 2018 | March 31, 2027 | REGNIER, MICHAEL | reporter.nih.gov |
| Molecular Atlas of the Cardiac Intercalated Disc | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,972,064 | January 20, 2022 | December 31, 2028 | DELMAR, MARIO | reporter.nih.gov |
| BIOREPOSITORY OF HUMAN INDUCED PLURIPOTENT STEM CELLSFORCARDIOVASCULAR DISEASES (BHIPSC-CVD)- TASK A. CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,969,819 | September 1, 2020 | August 31, 2025 | WU, JOSEPH | reporter.nih.gov |
| RSK3 Anchoring Disruptor Therapy for Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $3,961,080 | September 14, 2023 | July 31, 2025 | CIVIDINI, FEDERICO | reporter.nih.gov |
| Pulmonary Valved Graft with Regeneration Potential for Pediatric Patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,958,584 | May 24, 2019 | February 28, 2027 | HOUDE, AJAY | reporter.nih.gov |
| Exploring the relationship between advanced multimodal brain MRI phenotypes, genes and cognitive outcome in adults with CHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,938,586 | March 15, 2021 | February 28, 2027 | GRANT, PATRICIA ELLEN | reporter.nih.gov |
| Cardiovascular disease, metabolic syndrome, microbes and metabolites in FHS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,935,193 | February 1, 2022 | January 31, 2027 | XAVIER, RAMNIK J | reporter.nih.gov |
| Cardiac lineage determination and nuclear architecture | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,927,168 | January 1, 2018 | December 31, 2024 | EPSTEIN, JONATHAN A. | reporter.nih.gov |
| Imaging organ system interfaces in ischemic heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,920,729 | February 1, 2018 | January 31, 2025 | NAHRENDORF, MATTHIAS | reporter.nih.gov |
| Harnessing Artificial Intelligence and Deep Learning to Determine a Coronary Artery Calcium Estimate in Patients with No History of AtheroSclerotic CardioVascular Disease (HIDDEN-ASCVD) Study | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,918,561 | September 27, 2025 | August 31, 2029 | AMBROSY, ANDREW PATRICK | reporter.nih.gov |
| Targeting Skeletal Muscle Perfusion and Oxidative Capacity in HFpEF | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,911,878 | May 1, 2021 | April 30, 2027 | ZAMANI, PAYMAN | reporter.nih.gov |
| Transcatheter Device for Congestive Heart Failure Treatment Through Left Atrial Decompression | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,906,620 | September 1, 2018 | February 28, 2027 | PATE, THOMAS DIFFLEY | reporter.nih.gov |
| Atrial fibrillation ablation assessment and guidance using native-contrast T1 weighted MRI | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,901,042 | August 15, 2021 | June 30, 2027 | KOLANDAIVELU, ARAVINDAN | reporter.nih.gov |
| 1/2 PREEMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,886,403 | July 30, 2025 | June 30, 2027 | PAGIDIPATI, NEHA JADEJA | reporter.nih.gov |
| Targeting Mitochondria in Single Ventricle Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,873,722 | March 15, 2021 | January 31, 2026 | MIYAMOTO, SHELLEY DEANNE | reporter.nih.gov |
| Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,869,226 | May 1, 2018 | May 31, 2027 | WU, JOSEPH C. | reporter.nih.gov |
| Community Health Worker-Led Church-Based Intervention for Eliminating Cardiovascular Health Disparities in African Americans | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,868,770 | September 10, 2020 | August 31, 2027 | MILLS, KATHERINE TERESA | reporter.nih.gov |
| Managing Cardiac Toxicities of Cancer Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,865,725 | January 1, 2021 | December 31, 2027 | SALLOUM, FADI N | reporter.nih.gov |
| Prospective sudden cardiac death risk stratification using CMR and echocardiography machine learning in mitral valve prolapse | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,864,384 | May 26, 2020 | April 30, 2026 | DELLING, FRANCESCA N | reporter.nih.gov |
| A New and Disruptive Gene Based Therapy for Atrial Fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,849,106 | May 1, 2021 | December 31, 2025 | MOEN, ROBERT CHARLES | reporter.nih.gov |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK AREA A - CORE OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,838,691 | December 19, 2024 | April 11, 2025 | SIEGEL, JONATHAN H | reporter.nih.gov |
| Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health: An Adaptive Dose-Finding Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,834,860 | May 5, 2021 | April 30, 2027 | DIAZ, KEITH M | reporter.nih.gov |
| A novel behavioral intervention to promote adherence in heart failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,825,196 | July 1, 2021 | June 30, 2027 | CELANO, CHRISTOPHER M | reporter.nih.gov |
| Optical Tools to Assess the Role of Cardiac Function in the Development of Congenital Heart Defects | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,824,765 | July 1, 2015 | February 28, 2027 | JENKINS, MICHAEL W. | reporter.nih.gov |
| Jackson Heart Study (JHS) Field Center | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,819,327 | September 15, 2025 | September 14, 2026 | reporter.nih.gov | |
| Arterial stiffness in mother/infant dyads: Life course approach to prevent cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,814,826 | August 1, 2021 | July 31, 2025 | MEYER, MICHELLE | reporter.nih.gov |
| Catheter for Complex Percutaneous Coronary Intervention | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,814,040 | July 20, 2020 | January 31, 2027 | FISCHELL, TIM ALEXANDER | reporter.nih.gov |
| Harnessing Glycoproteomics and Glycomics to Understand Cardiac Biology and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,810,605 | February 1, 2021 | January 31, 2028 | GUNDRY, REBEKAH L. | reporter.nih.gov |
| Risk prediction and longitudinal assessment of cardiotoxicity and functional capacity trajectory in NSCLC patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,805,993 | June 1, 2021 | May 31, 2027 | LIAO, ZHONGXING | reporter.nih.gov |
| Utility of Esophageal Cooling Therapy for the Prevention of Thermal Injury During Atrial Fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,800,000 | September 15, 2021 | July 31, 2025 | KULSTAD, ERIK BENJAMIN | reporter.nih.gov |
| Jackson Heart Study (JHS) Coordinating Center: Task Area A - Core Study Operations | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,791,131 | September 15, 2025 | September 14, 2035 | reporter.nih.gov | |
| Exploring the Molecular Physiology of Atrial Fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,787,096 | January 17, 2018 | December 31, 2026 | MARX, STEVEN O | reporter.nih.gov |
| Mechanisms of Maladaptation in Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,769,610 | August 1, 1996 | May 31, 2027 | ROCKMAN, HOWARD A | reporter.nih.gov |
| Basic and Translational Studies in Redox Regulation of Cardiovascular Physiology and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,766,063 | January 1, 2022 | December 31, 2028 | STRAUB, ADAM CARL | reporter.nih.gov |
| Aspirin to prevent cardiac dysfunction in preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,760,353 | January 1, 2021 | December 31, 2026 | SHAHUL, SAJID | reporter.nih.gov |
| Positive and Negative Psychological Predictors of Long-Term Recovery after Cardiac Arrest | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,755,540 | January 5, 2021 | December 31, 2026 | BIRK, JEFFREY LEE | reporter.nih.gov |
| Testing Technology-Based Implementation Strategies for a Family-Based Pediatric Health Behavior Intervention in Community-Based Primary Care: A Cluster Randomized Factorial Trial | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,754,731 | September 15, 2023 | July 31, 2028 | BERKEL, CADY | reporter.nih.gov |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK AREA A - CORE OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,739,546 | December 19, 2024 | April 11, 2025 | PANKOW, JAMES S | reporter.nih.gov |
| CTSN | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,737,259 | July 15, 2013 | February 28, 2027 | STARNES, VAUGHN A | reporter.nih.gov |
| Cilia in Heart Development and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,728,670 | February 15, 2019 | January 31, 2026 | BRUECKNER, MARTINA | reporter.nih.gov |
| Investigating Mechanisms for Lipid Transport in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,725,279 | July 1, 2018 | June 30, 2025 | YOUNG, STEPHEN G. | reporter.nih.gov |
| Neurocognition and Greater Maintenance of Sinus Rhythm in AF (NOGGIN AF) | NIH | National Institute on Aging | 2021 to 2025 | $3,724,610 | September 1, 2021 | May 31, 2027 | MATHEW, JOSEPH P | reporter.nih.gov |
| Advanced Kidney Health Monitoring in Persons Hospitalized with Heart Failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,723,036 | September 30, 2021 | April 30, 2027 | ESTRELLA, MICHELLE M | reporter.nih.gov |
| Cardiogenesis: Molecular Mechanisms | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,717,603 | January 10, 1997 | May 31, 2028 | SRIVASTAVA, DEEPAK | reporter.nih.gov |
| Genetic modifiers of Duchenne Muscular Dystrophy | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $3,704,232 | May 15, 2014 | July 31, 2027 | FLANIGAN, KEVIN M | reporter.nih.gov |
| Cardiopulmonary Exercise MRI in Heart Failure with Preserved Ejection Fraction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,703,807 | September 1, 2021 | August 31, 2026 | NEZAFAT, REZA | reporter.nih.gov |
| Protein structural biophysics driving drug discovery for cardiac calcium transport regulation, producing translational advances and mechanistic insights | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,701,653 | May 1, 2020 | April 30, 2028 | THOMAS, DAVID D | reporter.nih.gov |
| IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,701,419 | April 15, 2009 | March 31, 2026 | ELLINOR, PATRICK THOMAS | reporter.nih.gov |
| Structural Basis for Antiarrhythmic Drug Action | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,695,517 | April 6, 2012 | April 30, 2027 | ZHENG, NING | reporter.nih.gov |
| Inflammation and thrombosis fuel cardiovascular and pulmonary disease: Focus on the interplay of neutrophil inflammasomes with NETs | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,692,220 | March 15, 2023 | February 28, 2030 | WAGNER, DENISA D | reporter.nih.gov |
| Peripheral Sympathetic Dysfunction in Cardiac Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,691,327 | April 1, 2020 | April 30, 2028 | HABECKER, BETH A | reporter.nih.gov |
| Influencing Basic Behavioral Mechanisms of Action while targeting Daily Walking in Those at Risk for Cardiovascular Disease: Science of Behavior Change Factorial Experiment of Behavioral Change | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,687,122 | July 1, 2021 | June 30, 2026 | DAVIDSON, KARINA W. | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) GRADUATE TRAINING AND EDUCATION CENTER (GTEC) - TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,682,352 | August 13, 2023 | August 12, 2025 | RENEKER, JENNIFER | reporter.nih.gov |
| Cardiac Lineage-Specific Molecular Mechanisms of Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,682,052 | February 1, 2021 | January 31, 2025 | CHI, NEIL C | reporter.nih.gov |
| Mapping spatiotemporal dynamics during enterovirus infection across cells and tissues | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,677,462 | March 10, 2022 | February 28, 2027 | ANDINO, RAUL | reporter.nih.gov |
| Magnetic Resonance Imaging Guided Robotic Catheter System for Left Atrial Appendage Occlusion Procedures | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,666,425 | July 15, 2022 | June 30, 2027 | CAVUSOGLU, M. CENK | reporter.nih.gov |
| Reducing disparities in cardiovascular health in community mental health settings: optimizing implementation strategies | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,663,171 | September 10, 2020 | August 31, 2027 | DAUMIT, GAIL L. | reporter.nih.gov |
| Mechanism of Myocardial Fibrosis Induced by Mitral Valve Prolapse | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,657,264 | September 5, 2024 | July 31, 2028 | LEVINE, ROBERT A | reporter.nih.gov |
| Structural Determinants of PIP2 Regulation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,657,236 | April 1, 1998 | May 31, 2028 | LOGOTHETIS, DIOMEDES E. | reporter.nih.gov |
| Improving Tissue Engineered Vascular Graft Performance via Computational Modeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,638,571 | January 1, 2018 | March 31, 2027 | BREUER, CHRISTOPHER KANE | reporter.nih.gov |
| Nourexal™: A Novel Bioenergetic Drug to Increase Donor Heart Utilization | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,632,845 | September 20, 2024 | June 30, 2026 | ELGEBALY, SALWA A | reporter.nih.gov |
| The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF) | NIH | National Heart, Lung, and Blood Institute | 2022 | $3,610,112 | August 25, 2022 | July 31, 2023 | PASSMAN, ROD S | reporter.nih.gov |
| Development of ureadepsipetides for drug-resistant infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,597,406 | December 17, 2018 | November 30, 2024 | LAFLEUR, MICHAEL | reporter.nih.gov |
| Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) accelerates atherosclerotic plaque progression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,595,504 | February 1, 2022 | June 30, 2026 | SHAW, LESLEE J | reporter.nih.gov |
| Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children | NIH | National Cancer Institute | 2021 to 2025 | $3,570,931 | August 5, 2021 | July 31, 2026 | BURRIDGE, PAUL W. | reporter.nih.gov |
| Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,569,593 | April 1, 2019 | April 30, 2027 | WU, JOSEPH C. | reporter.nih.gov |
| Prophylactic Intra-Operative VT Ablation in High-Risk LVAD Candidates | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,569,437 | July 1, 2021 | June 30, 2027 | HUANG, DAVID T | reporter.nih.gov |
| 1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $3,567,710 | May 15, 2019 | August 31, 2022 | GLADWIN, MARK T | reporter.nih.gov |
| Reducing maternal prenatal depression to improve child cardiovascular health | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,556,305 | January 15, 2021 | December 31, 2026 | DAVIS, ELYSIA POGGI | reporter.nih.gov |
| RACE-CARS DCC 2/2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,545,654 | July 1, 2020 | June 30, 2027 | AL-KHALIDI, HUSSEIN | reporter.nih.gov |
| PP2A Anchoring Disruptor Therapy in Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,544,947 | September 1, 2021 | August 31, 2025 | CIVIDINI, FEDERICO | reporter.nih.gov |
| The Identification of Modifiable Emergency Department and Sleep Factors Contributing to Psychological and Cardiovascular Risk in Clinicians | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,539,571 | January 1, 2020 | December 31, 2025 | CHANG, BERNARD P. | reporter.nih.gov |
| Tricuspid Valve Maladaptation: Its Stimuli, its Effect on Valve Function, and its Response to Therapy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,537,887 | June 20, 2022 | May 31, 2027 | RAUSCH, MANUEL KARL | reporter.nih.gov |
| Ultrasound Targeted Microbubble Cavitation to Treat Coronary Microvascular Obstruction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,534,234 | May 17, 2021 | April 30, 2027 | PACELLA, JOHN J | reporter.nih.gov |
| SALSA - Study of Active Lifestyle Activation | NIH | National Cancer Institute | 2021 to 2025 | $3,527,531 | September 21, 2021 | August 31, 2026 | CHOW, ERIC JESSEN | reporter.nih.gov |
| Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,522,987 | July 5, 2016 | May 31, 2027 | CHEN, HONG | reporter.nih.gov |
| Connexin-based Signaling in the Heart: Cellular and Exosomal | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,522,131 | January 20, 2022 | December 31, 2028 | GOURDIE, ROBERT G | reporter.nih.gov |
| 1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,521,212 | September 15, 2020 | August 31, 2025 | BERGER, STUART | reporter.nih.gov |
| CaMKII activation and regulation in adult cardiac myocytes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,518,189 | April 18, 2018 | June 30, 2026 | BERS, DONALD M | reporter.nih.gov |
| Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,518,173 | February 1, 2023 | January 31, 2028 | BEATON, ANDREA ZAWACKI | reporter.nih.gov |
| Circulating levels of Persistent Organic Pollutants and Subclinical Atherosclerosis progression in Postmenopausal women | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $3,506,220 | September 20, 2022 | July 31, 2027 | KARIM, ROKSANA | reporter.nih.gov |
| Proteomics profiling in hypertrophic cardiomyopathy and cardiac event prediction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,497,937 | April 1, 2021 | March 31, 2027 | SHIMADA, YUICHI | reporter.nih.gov |
| Improving Blood Pressure Screening and Treatment Strategies in Young Adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,497,809 | July 1, 2021 | May 31, 2027 | AN, JAEJIN | reporter.nih.gov |
| Association of Posttraumatic Stress Disorder with Cardiac Electrical Instability: A Twin Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,492,282 | July 1, 2021 | June 30, 2027 | SHAH, AMIT JASVANT | reporter.nih.gov |
| Optimize Risk Assessment for Incident and Recurrent Atherosclerotic Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,484,566 | July 15, 2021 | June 30, 2027 | ZHANG, YIYI | reporter.nih.gov |
| Sleep Apnea-Specific Nocturnal Blood Pressure Surge to Determine Cardiovascular Risks and Therapeutic Benefits in Patients with Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,481,554 | September 1, 2021 | July 31, 2027 | KWON, YOUNGHOON | reporter.nih.gov |
| Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,475,737 | September 15, 2020 | August 31, 2025 | VAIDYA, ANAND | reporter.nih.gov |
| Cardiac Imaging of Neuro-Embolic Mechanisms in Atriopathies causing Stroke (CINEMAS) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,473,396 | May 1, 2024 | April 30, 2029 | GOLDBERGER, JEFFREY J | reporter.nih.gov |
| Disparities in cardiovascular health in young adults with type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,472,802 | September 1, 2024 | May 31, 2028 | DABELEA, DANA | reporter.nih.gov |
| Multidrug Metabolic Approach to Improve Exercise and Skeletal Muscle Oxidative Capacity in HFpEF | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,467,457 | July 1, 2021 | May 31, 2027 | ZAMANI, PAYMAN | reporter.nih.gov |
| Patterns of Cardiopulmonary health across the life course | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,464,936 | September 1, 2021 | May 31, 2027 | KHAN, SADIYA SANA | reporter.nih.gov |
| Leveraging zebrafish models to dissect and enhance heart regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,454,465 | May 15, 2020 | December 31, 2024 | POSS, KENNETH D | reporter.nih.gov |
| A phase I trial of AdKCNH2-G628S gene therapy for post-op atrial fibrillation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $3,447,560 | September 15, 2021 | August 31, 2024 | DONAHUE, J KEVIN | reporter.nih.gov |
| The Trajectories and Clinical Experiences of ICD Therapy (TRACER-ICD) Study | NIH | National Institute on Aging | 2021 to 2025 | $3,439,497 | April 15, 2021 | March 31, 2027 | KRAMER, DANIEL BRUCE | reporter.nih.gov |
| L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,437,123 | December 20, 2020 | December 31, 2028 | LOSCALZO, JOSEPH | reporter.nih.gov |
| Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health | NIH | National Cancer Institute | 2021 to 2025 | $3,435,650 | April 1, 2022 | March 31, 2027 | MONTGOMERY, GUY H | reporter.nih.gov |
| Dual-modality FLIm and PSOCT for intravascular imaging of plaque in patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,431,403 | September 10, 2021 | August 31, 2026 | MARCU, LAURA | reporter.nih.gov |
| Urban Greenness and Cardiovascular Health | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,430,350 | July 1, 2018 | May 31, 2029 | BHATNAGAR, ARUNI | reporter.nih.gov |
| New Approaches to Mitigate Left Ventricular Injury with VA-ECMO in Acute Myocardial Infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,429,326 | August 1, 2021 | July 31, 2025 | KAPUR, NAVIN KUMAR | reporter.nih.gov |
| 2/2 Pediatric Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,424,003 | September 15, 2021 | August 31, 2028 | YEATTS, SHARON DZIUBA | reporter.nih.gov |
| Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,417,341 | January 15, 2022 | December 31, 2028 | LAVINE, KORY J. | reporter.nih.gov |
| Community Intervention to Reduce CardiovascuLar Disease in Chicago (CIRCL-Chicago) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,414,401 | September 10, 2020 | August 31, 2027 | KHO, ABEL N. | reporter.nih.gov |
| Factors Associated with Response to Cardiac Resynchronization Therapy in Heart Failure Patients with Non-LBBB ECG Pattern | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,413,377 | July 8, 2021 | June 30, 2027 | KUTYIFA, VALENTINA | reporter.nih.gov |
| SUPPORT-AF IV | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,411,751 | August 1, 2021 | June 30, 2027 | KAPOOR, ALOK | reporter.nih.gov |
| Uncovering early signals of hereditary TTR amyloidosis in minority populations at high genetic risk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,411,450 | April 1, 2021 | March 31, 2027 | KONTOROVICH, AMY R. | reporter.nih.gov |
| SBIR TOPIC 112, FAST-TRACK, INTRAMYOCARDIAL SUTURE ANNULOPLASTY SYSTEM ("MIRTH" AND "SCIMITAR" DEVICES) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $3,399,623 | April 1, 2022 | March 31, 2026 | RAFIEE, NASSER | reporter.nih.gov |
| Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,398,319 | January 15, 2019 | December 31, 2024 | LEEPER, NICHOLAS JAMES | reporter.nih.gov |
| Non-Invasive Venous Waveform Analysis (NIVA) in patients with Heart Failure (HF) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,395,960 | August 21, 2018 | February 28, 2027 | HOCKING, KYLE MITCHELL | reporter.nih.gov |
| Avoiding (Heart) Failure: Physiologic-Based Targeting of the RAAS to Treat Subclinical HFpEF among PWH | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,365,562 | January 15, 2020 | December 31, 2025 | SRINIVASA, SUMAN | reporter.nih.gov |
| Applying Digital Health to the AF Ablation NCDR, Enabling Longitudinal Follow-up | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,363,830 | September 16, 2021 | July 31, 2026 | MARCUS, GREGORY M | reporter.nih.gov |
| Elucidating hereditary transthyretin-mediated heart failure risk using machine learning, polygenic risk and recall by genotype approaches in African ancestry individuals | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,362,751 | February 15, 2021 | January 31, 2026 | DO, RON | reporter.nih.gov |
| Cardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,354,566 | September 1, 2021 | July 31, 2027 | KIM, JIWON | reporter.nih.gov |
| Elucidating Anthracycline-Induced Cell Type-Specific Cardiovascular Toxicity with CRISPRi/a Screens | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,345,164 | September 1, 2025 | August 31, 2030 | WU, JOSEPH C. | reporter.nih.gov |
| Informing optimal first-line antihypertensive therapy: A rigorous comparative effectiveness analysis of ARBs vs. ACEIs on long-term risk of dementia, cancer, heart disease, and quality of life | NIH | National Institute on Aging | 2022 to 2025 | $3,339,134 | March 15, 2022 | December 31, 2026 | COHEN, JORDANA B. | reporter.nih.gov |
| Genetic Control of Cardiac Development: Congenital Heart Disease Gene Discovery in Drosophila | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,338,929 | August 1, 1995 | June 30, 2025 | BODMER, ROLF | reporter.nih.gov |
| Randomized comparison of the clinical Outcome of single versus Multiple Arterial grafts: Quality of Life (ROMA:QOL) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,332,837 | April 21, 2020 | March 31, 2026 | GAUDINO, MARIO FL | reporter.nih.gov |
| Molecular Regulation of Atherosclerosis Regression - Renewal | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,330,002 | April 1, 2006 | February 28, 2026 | FISHER, EDWARD A | reporter.nih.gov |
| 1/2 – Pediatric Prehospital Airway Resuscitation Trial | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,328,856 | September 1, 2023 | July 31, 2029 | WANG, HENRY E. | reporter.nih.gov |
| Using genetic variation to study biology of blood lipids & coronary heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,324,792 | April 1, 2015 | June 30, 2026 | PELOSO, GINA MARIE | reporter.nih.gov |
| Mechanism of Glucose-dependent insulinotropic polypeptide (GIP) on Splanchnic Venous Capacitance in Postural Tachycardia Syndrome | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,322,582 | August 1, 2022 | May 31, 2027 | SHIBAO, CYNDYA ADRIANA | reporter.nih.gov |
| Exosome Therapeutics to Dissect HFpEF Mechanisms | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,321,034 | July 1, 2021 | June 30, 2025 | VAN EYK, JENNIFER E | reporter.nih.gov |
| Graft extracellular vesicles as promoters of anti-donor immunity in cardiac and skin transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,318,431 | September 19, 2022 | July 31, 2027 | MORELLI, ADRIAN E. | reporter.nih.gov |
| Apolipoprotein C3-loading of apolipoprotein B100 lipoproteins and cardiovascular disease in patients with type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,318,186 | January 5, 2022 | December 31, 2026 | HEINECKE, JAY W | reporter.nih.gov |
| Stress and Cardiovascular Risk Among Urban African American adults: A Multilevel, Mixed Methods Approach | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,312,736 | April 20, 2021 | March 31, 2027 | ZILIOLI, SAMUELE | reporter.nih.gov |
| A Randomized Trial of Protocolized Diuretic Therapy Compared to Standard Care in Emergency Department Patients with Acute Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,310,531 | September 1, 2021 | August 31, 2026 | COLLINS, SEAN PATRICK | reporter.nih.gov |
| Mechanisms and interventions addressing accelerated cardiovascular disease risk in women with endometriosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,309,680 | January 5, 2022 | December 31, 2026 | ALEXANDER, LACY M. | reporter.nih.gov |
| Comprehensive Cardiac Structure-Function Analysis in Heart Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,301,355 | February 4, 2014 | April 30, 2027 | MARKL, MICHAEL | reporter.nih.gov |
| A comprehensive valvular heart disease assessment with stress cardiac MRI | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,300,360 | August 1, 2021 | July 31, 2027 | AHMAD, RIZWAN | reporter.nih.gov |
| Assessment of Mast Cell Degranulation in Infarcted Myocardium Using Quantitative Multiparametric MRI | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,298,936 | July 1, 2022 | June 30, 2027 | LI, DEBIAO | reporter.nih.gov |
| Mechanical Load Effects on Cardiac Function and Heart Diseases | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,297,090 | March 1, 2023 | February 28, 2030 | CHEN-IZU, YE | reporter.nih.gov |
| Young Adult and Midlife Transitions in Physical Activity and Sedentary Behavior with Heart Failure Risk and Progression: Coronary Artery Risk Development in Young Adults (CARDIA) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,296,238 | August 1, 2020 | July 31, 2025 | GABRIEL, KELLEY PETTEE | reporter.nih.gov |
| Cardioscopically-guided Valve Repair in the Beating Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,285,122 | July 22, 2014 | March 31, 2026 | DUPONT, PIERRE E | reporter.nih.gov |
| Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive Adults | NIH | National Institute on Drug Abuse | 2021 to 2024 | $3,280,008 | July 1, 2020 | May 31, 2025 | FANTRY, LORI E | reporter.nih.gov |
| Dyadic Health Consequences of Distress in Patients and their Partners After an Acute Cardiovascular Event | NIH | National Institute on Aging | 2025 | $3,273,481 | September 1, 2025 | August 31, 2029 | CORNELIUS, TALEA | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) COMMUNITY ENGAGEMENT CENTER - TASK AREA B: DEMONSTRATION PROJECTS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,272,668 | September 25, 2023 | September 24, 2024 | SUTTON, VICTOR D | reporter.nih.gov |
| Immune Activation and Region-specific Myocardial Arrhythmic Substrate in Sudden Cardiac Death Victims with HIV | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,264,423 | September 1, 2025 | August 31, 2029 | TSENG, ZIAN H | reporter.nih.gov |
| Regulation of Cardiac Calcium Transport | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,264,334 | July 1, 2008 | June 30, 2027 | ROBIA, SETH L | reporter.nih.gov |
| Vascular Dysfunction in Myocardial Ischemia and Metabolic Syndrome | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,258,608 | April 1, 2016 | June 30, 2027 | SELLKE, FRANK W | reporter.nih.gov |
| Metabolic Responses to an Oral Mixed Meal Tolerance Test: Intra-individual changes, correlates, and prognostic significance | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,257,323 | August 20, 2021 | June 30, 2026 | NAYOR, MATTHEW G. | reporter.nih.gov |
| Mitochondrial-targeted antioxidant supplementation for improving age-related vascular dysfunction in humans | NIH | National Institute on Aging | 2021 to 2025 | $3,256,259 | January 1, 2021 | December 31, 2026 | SEALS, DOUGLAS R | reporter.nih.gov |
| Hepcidin-Ferroportin-Iron Axis in Cardiac Surgery-associated Acute Kidney Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,251,509 | July 15, 2022 | May 31, 2026 | LEAF, DAVID EVAN | reporter.nih.gov |
| PET Imaging of Thrombus | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,247,850 | August 1, 2011 | January 31, 2027 | CARAVAN, PETER D | reporter.nih.gov |
| Precision MRI of Left Atrial Fibrosis for Patients with Atrial Fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,234,198 | February 1, 2014 | February 28, 2027 | KIM, DANIEL | reporter.nih.gov |
| Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young Children | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,231,750 | August 15, 2016 | February 28, 2029 | HARRINGTON, DANIEL A | reporter.nih.gov |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK A - CORE OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,230,987 | December 19, 2024 | April 11, 2025 | POST, WENDY S | reporter.nih.gov |
| Mitochondrial health, cardiovascular risk, and blood pressure targets in hypertensive adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,222,133 | September 1, 2021 | July 31, 2026 | JOTWANI, VASANTHA KOLAVENNU | reporter.nih.gov |
| The epigenetic regulation of inflammation in tissue repair and vascular disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,217,378 | July 1, 2023 | June 30, 2030 | GALLAGHER, KATHERINE ANN | reporter.nih.gov |
| Exercise Intolerance in Non Obstructive Hypertrophic Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,213,836 | May 1, 2022 | February 28, 2027 | ABRAHAM, THEODORE P | reporter.nih.gov |
| Calcium and MAPKinase Signaling and Structural Remodeling in Atrial Fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,213,482 | May 1, 2021 | April 30, 2026 | DONAHUE, J KEVIN | reporter.nih.gov |
| The Hemodynamic and Metabolic Effects of Advanced Circulatory Support for Resuscitation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,211,098 | March 15, 2021 | February 28, 2026 | HALPERIN, HENRY R | reporter.nih.gov |
| Probing the biochemical mechanism of amyloid disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,210,642 | May 1, 1993 | June 30, 2026 | KELLY, JEFFERY W | reporter.nih.gov |
| Multi-ethnic Multi-level Strategies and Behavioral Economics to Eliminate Hypertension Disparities in LA County. | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,206,956 | September 10, 2020 | August 31, 2027 | BROWN, ARLEEN F. | reporter.nih.gov |
| Preconception and prenatal stress effects on cardiovascular disease risk in black women | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,206,913 | September 15, 2020 | July 31, 2025 | HIPWELL, ALISON E | reporter.nih.gov |
| Microstructural Response of the Myocardium to Mechanical Load | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,205,295 | July 1, 2021 | May 31, 2026 | SOSNOVIK, DAVID E | reporter.nih.gov |
| PRISM: Ethically-guided multimodal AI models for predicting disease pathogenesis in individuals with pathogenic variants | NIH | National Human Genome Research Institute | 2025 | $3,203,253 | September 2, 2025 | August 31, 2027 | KARCZEWSKI, KONRAD | reporter.nih.gov |
| Myocardial Steatosis in Women with Coronary Microvascular Dysfunction: Defining the Pathway to Heart Failure with Preserved Ejection Fraction (HFpEF) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,202,489 | July 1, 2021 | June 30, 2026 | WEI, JANET | reporter.nih.gov |
| Early myocardial remodeling and progressive kidney function decline in type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,199,007 | December 24, 2021 | November 30, 2026 | DORIA, ALESSANDRO | reporter.nih.gov |
| The state of energy in the right ventricle of patients with pulmonary arterial hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,198,508 | January 15, 2022 | December 31, 2026 | KHERADVAR, ARASH | reporter.nih.gov |
| Clonal Hematopoeisis of Indeterminate Potential and Risk of Autopsy-defined Sudden Cardiac Death | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,193,873 | December 1, 2021 | November 30, 2026 | TSENG, ZIAN H | reporter.nih.gov |
| Early Developmental Risk for Adult Cardiovascular Disease: High risk Subgroups, Biomarkers, and Mechanisms | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,193,149 | August 1, 2024 | May 31, 2028 | BUKA, STEPHEN L | reporter.nih.gov |
| Supraphysiologic Shear Stresses Associated with Cardiopulmonary Bypass are Sufficient to Activate RIKP3 Signaling | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $3,190,231 | April 11, 2022 | February 28, 2027 | NIGAM, VISHAL | reporter.nih.gov |
| Elucidating Mechanistic Relationships Between Atrial Ectopy, Atrial Remodeling and Atrial Fibrillation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,189,073 | July 1, 2022 | June 30, 2027 | GERSTENFELD, EDWARD PAUL | reporter.nih.gov |
| Genetic Architecture of Cardiac Structure and Function and Its Impact on Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,188,215 | August 1, 2022 | June 30, 2027 | YU, BING | reporter.nih.gov |
| Assessing Effects of Microgravity on Cardiovascular Aging with AI and 3D Organoids | NIH | National Center for Advancing Translational Sciences | 2025 | $3,183,188 | August 1, 2025 | June 30, 2028 | WU, JOSEPH C. | reporter.nih.gov |
| Development of a first-in-class nonmuscle myosin II inhibitor to prevent substance use disorder relapse | NIH | National Institute on Drug Abuse | 2021 to 2023 | $3,182,913 | September 30, 2021 | August 31, 2024 | YOUNG, ERICA J | reporter.nih.gov |
| Impact of Interventions on Future Trends in Subnational Burden of Cardiovascular Diseases in the US | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,182,562 | September 22, 2018 | May 31, 2029 | ROTH, GREGORY ANDREW | reporter.nih.gov |
| Transcriptional regulation of chamber selective gene expression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,177,317 | March 1, 2021 | May 31, 2029 | PU, WILLIAM TSWENCHING | reporter.nih.gov |
| Single-cell Multi-omic Profiling of Drug Responses Using Pooled iPSC-CM Differentiation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,175,574 | May 1, 2019 | April 30, 2027 | WU, JOSEPH C. | reporter.nih.gov |
| NAD+ precursor supplementation with exercise training to improve aerobic capacity in Friedreich's Ataxia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,169,156 | January 1, 2020 | December 31, 2025 | MCCORMACK, SHANA ERIN | reporter.nih.gov |
| Microphysiological Model of Human Cardiac Sympathetic Innervation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,165,021 | July 1, 2022 | June 30, 2027 | KIM, DEOK-HO | reporter.nih.gov |
| Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,160,264 | December 24, 2021 | November 30, 2025 | KING, GEORGE L | reporter.nih.gov |
| Polygenic Risk of Disease in Populations of Diverse Ancestry | NIH | National Human Genome Research Institute | 2021 to 2025 | $3,159,052 | September 8, 2021 | April 30, 2027 | SCHAID, DANIEL J. | reporter.nih.gov |
| DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,158,101 | August 6, 2021 | December 31, 2027 | TANG, BEVERLY | reporter.nih.gov |
| Endothelial Cell to Mesenchymal Cell Transitions Play a Critical Biological Sex- and Aging-Dependent Role in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,155,829 | January 1, 2022 | December 31, 2025 | OWENS, GARY K | reporter.nih.gov |
| Implementation of EMR-Integrated Referrals to Link Clinical and Community Services to Reduce Health Inequity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,154,440 | January 1, 2020 | December 31, 2025 | DAVE, GAURAV J | reporter.nih.gov |
| Investigating Mixed Lineage Kinase 3 as a blood pressure-independent protein kinase G1 effector in heart failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,153,099 | May 15, 2022 | April 30, 2027 | BLANTON, ROBERT MORRIS | reporter.nih.gov |
| Engineering Vascularized Cardiac Muscle | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,149,452 | July 1, 2005 | March 31, 2027 | VUNJAK-NOVAKOVIC, GORDANA | reporter.nih.gov |
| Multiscale mechanobiology of right ventricular failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,148,570 | July 1, 2020 | June 30, 2025 | CHESLER, NAOMI C | reporter.nih.gov |
| Supply and Demand: Oxygen and Workload Regulate Cardiomyocyte Proliferation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,145,077 | February 15, 2023 | February 28, 2025 | SADEK, HESHAM | reporter.nih.gov |
| Discovery and interrogation of genetic regulatory variation impacting Atrial Fibrillation risk | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,144,696 | April 1, 2022 | March 31, 2026 | MOSKOWITZ, IVAN PAUL | reporter.nih.gov |
| L-type channel trafficking and modulation in heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,142,708 | August 1, 2014 | April 30, 2027 | COLECRAFT, HENRY M. | reporter.nih.gov |
| Molecular control of cardiac regenerative potential | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,142,578 | December 1, 2017 | December 31, 2026 | HUANG, GUO | reporter.nih.gov |
| Chemokines in healing myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,140,955 | June 6, 2005 | May 31, 2028 | FRANGOGIANNIS, NIKOLAOS G | reporter.nih.gov |
| Preclinical Assessment of a Compliance Matched Biopolymer Vascular Graft | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,139,611 | December 15, 2021 | November 30, 2026 | VANDE GEEST, JONATHAN PIETER | reporter.nih.gov |
| Mechanisms of atherosclerotic cardiovascular complications | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,139,538 | September 1, 2022 | August 31, 2026 | GIANNARELLI, CHIARA | reporter.nih.gov |
| The role of signaling adaptor protein epsin in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,138,613 | December 15, 2020 | November 30, 2025 | CHEN, HONG | reporter.nih.gov |
| Structure/Function of Channelrhodopsins and Related Retinylidene Proteins | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,136,850 | May 1, 2021 | February 28, 2027 | SPUDICH, JOHN LEE | reporter.nih.gov |
| High-throughput investigation of human genetic variants affecting cholesterol uptake and efflux | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,136,707 | July 1, 2022 | June 30, 2026 | SHERWOOD, RICHARD I | reporter.nih.gov |
| Intersection of Material-Need Insecurities and HIV and Cardiovascular Health | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,136,527 | August 4, 2020 | June 30, 2026 | WEISER, SHERI DAWN | reporter.nih.gov |
| Mechanistic Basis of Cardiac Irradiation as a Therapy for Ventricular Tachycardia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,133,298 | June 1, 2022 | May 31, 2027 | RENTSCHLER, STACEY LYNN | reporter.nih.gov |
| Characterize psychological and behavioral dimensions of cardiac arrest survivorship, and their association with 1-year mortality, cardiovascular disease risk, and health-related quality of life | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,127,696 | September 1, 2021 | July 31, 2025 | AGARWAL, SACHIN | reporter.nih.gov |
| Pediatric Heart Network Data Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,125,882 | January 1, 2025 | December 31, 2031 | MILLER, JULIE ELAINE | reporter.nih.gov |
| Mental Stress Reactivity in Women with Coronary Microvascular Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,125,714 | January 1, 2022 | April 29, 2025 | MEHTA, PUJA KIRAN | reporter.nih.gov |
| Molecular Imaging of Collagen Turnover in Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,124,954 | July 1, 2022 | June 30, 2027 | SADEGHI, MEHRAN M | reporter.nih.gov |
| Push-Button Cardiac MRI for Non-Invasive Quantification of Myocardial Energy Consumption in Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,123,890 | August 15, 2022 | June 30, 2027 | YANG, HSIN-JUNG | reporter.nih.gov |
| Targeted immune therapies in heart transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,118,293 | February 1, 2023 | January 31, 2026 | ABDI, REZA | reporter.nih.gov |
| Investigation of Sex and Gender Differences in Cardiovascular Risk in Rural Communities | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,116,310 | March 1, 2023 | February 29, 2028 | SHAH, AMIT JASVANT | reporter.nih.gov |
| Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 Survivors | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,114,564 | January 20, 2022 | December 31, 2026 | CHIRINOS MEDINA, JULIO ALONSO | reporter.nih.gov |
| Blood Pressure and ADRD in African Americans: the Jackson Heart Study | NIH | National Institute on Aging | 2021 to 2022 | $3,111,832 | September 15, 2019 | August 31, 2022 | PALTA, PRIYA | reporter.nih.gov |
| An evaluation of insomnia treatment to reduce cardiovascular risk in patients with posttraumatic stress disorder | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,107,795 | July 1, 2020 | June 30, 2026 | BECKHAM, JEAN C. | reporter.nih.gov |
| Novel application of Digital signals of movement, sleep and heart rhythms for detection of Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2022 to 2025 | $3,104,339 | September 30, 2022 | June 30, 2027 | SCHRACK, JENNIFER ANN | reporter.nih.gov |
| Cardiovascular Consequences of Duchenne and Becker Muscular Dystrophinopathies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,104,268 | September 1, 2021 | August 31, 2027 | WITMAN, MELISSA A.H. | reporter.nih.gov |
| Cardiovascular risk from comprehensive evaluation of the CT calcium score exam | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,104,134 | March 15, 2023 | February 28, 2027 | WILSON, DAVID LYNN | reporter.nih.gov |
| Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection. | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,103,804 | March 18, 2022 | February 28, 2027 | JONES, KATHRYN MARIE | reporter.nih.gov |
| Membrane-active quinoline and quinazoline antibacterials that target Gram positive pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,102,056 | March 1, 2020 | February 28, 2026 | CHEUNG, AMBROSE LIN YAU | reporter.nih.gov |
| Regulation of Myocardial Phospholipases and Lipases in Diabetic Myocardium | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,101,106 | June 1, 2013 | January 31, 2026 | GROSS, RICHARD W | reporter.nih.gov |
| Discovery, Replication, and Validation of Biomarkers of the DASH Diet and Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,096,045 | September 1, 2021 | July 31, 2026 | REBHOLZ, CASEY MARIE | reporter.nih.gov |
| Development of End-To-End Clinical Decision Support Tools To Prevent Cardiotoxic Drug Response | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,093,709 | February 1, 2020 | January 31, 2026 | ROSENBERG, MICHAEL A | reporter.nih.gov |
| Heart Matters: Collaborate and Leverage Evidence in an African American Rural Network to Implement Risk Reduction Strategies for CVD (Heart Matters: Co-Learn to Reduce CVD) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,091,538 | August 15, 2021 | July 31, 2027 | DAVE, GAURAV | reporter.nih.gov |
| Cardiovascular MRI Characterization of the Arrhythmogenic Heart in Nonischemic Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,091,249 | August 15, 2015 | June 30, 2026 | NEZAFAT, REZA | reporter.nih.gov |
| Aspirin-triggered Specialized Pro-resolving Mediators in Increasing Weight and Atherosclerotic Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,089,508 | April 1, 2021 | March 31, 2027 | HEFFRON, SEAN PATRICK | reporter.nih.gov |
| MR-compatible Devices for the Diagnosis and Treatment of Cardiomyopathies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,089,138 | August 20, 2021 | June 30, 2025 | KRAITCHMAN, DARA L | reporter.nih.gov |
| 2-HOBA for Treatment of Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,088,886 | September 1, 2021 | August 31, 2026 | RATHMACHER, JOHN A | reporter.nih.gov |
| Development of a Universal Bi-ventricular Replacement System for the Failing Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,085,748 | May 1, 2021 | April 30, 2026 | CYSYK, JOSHUA P | reporter.nih.gov |
| Community Health Worker-Led Church-Based Intervention for Eliminating Cardiovascular Health Disparities in African Americans | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $3,081,890 | September 10, 2020 | August 31, 2023 | HE, JIANG | reporter.nih.gov |
| Systems Pharmacology Model of Cardiac Hypertrophy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,081,718 | April 1, 2022 | March 31, 2027 | SAUCERMAN, JEFFREY J. | reporter.nih.gov |
| Resolution of inflammation in healing myocardial infarcts | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,081,125 | January 15, 2008 | December 31, 2026 | FRANGOGIANNIS, NIKOLAOS G | reporter.nih.gov |
| Molecular and Functional Taxonomy of Cardiovagal Neurons | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,077,354 | July 1, 2021 | June 30, 2026 | CAMPBELL, JOHN NELSON | reporter.nih.gov |
| Investigating Cardiac Ion Channels by Novel Methods | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,076,196 | June 5, 2021 | May 31, 2029 | MARX, STEVEN O | reporter.nih.gov |
| Administrative Supplement to Promote Diversity in Research and Development Small Businesses-SBIR (EF) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,074,836 | April 15, 2020 | March 31, 2024 | KALE, KAUSTUBH | reporter.nih.gov |
| Regulation and Dysregulation of Cardiac EC coupling by Calmodulin | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,073,271 | July 1, 2017 | March 31, 2027 | GYORKE, SANDOR | reporter.nih.gov |
| Genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,070,980 | February 1, 2022 | January 31, 2027 | MORROW, BERNICE E | reporter.nih.gov |
| Genetic determinants of 4D genome folding in human cardiac development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,069,960 | September 21, 2020 | August 31, 2025 | BRUNEAU, BENOIT GAETAN | reporter.nih.gov |
| Mechanobiology of Cardiac Outflow Tract Morphogenesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,068,575 | March 15, 2022 | February 28, 2027 | BUTCHER, JONATHAN TALBOT | reporter.nih.gov |
| Animal Models for Studying the Genetics of Complex Diseases | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,068,389 | September 30, 1992 | December 31, 2026 | MAEDA, NOBUYO | reporter.nih.gov |
| Ferumoxytol-Enhanced Cardiac MRI for Ischemic Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,066,463 | July 1, 2020 | June 30, 2026 | NGUYEN, KIM-LIEN T | reporter.nih.gov |
| Signaling To and From the Vascular/Endothelial Compartment and Progression of HCM Linked to Sarcomere Mutations | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,065,794 | April 1, 2022 | March 31, 2027 | WOLSKA, BEATA M. | reporter.nih.gov |
| Apolipoprotein M: a novel regulator of myocardial Autophagy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,065,388 | September 1, 2021 | August 31, 2026 | JAVAHERI, ALI | reporter.nih.gov |
| Metabolic profiling and comprehensive metabolic pathway mapping: a systems biology approach to cardiovascular failure and organ injury following infant congenital heart disease surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,061,754 | May 1, 2021 | April 30, 2027 | DAVIDSON, JESSE | reporter.nih.gov |
| Gene-by-environment interactions that affect exposure-mediated congenital heart disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,058,037 | September 10, 2021 | June 30, 2027 | WHITEHEAD, JOHN ANDREW | reporter.nih.gov |
| Causal variant association mechanisms in TCF21 binding coronary disease loci | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,054,012 | January 1, 2017 | November 30, 2028 | QUERTERMOUS, THOMAS | reporter.nih.gov |
| Cardiac Fibroblasts in Postnatal Development and Adult Injury Response | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,053,017 | July 1, 2018 | March 31, 2027 | YUTZEY, KATHERINE E | reporter.nih.gov |
| Direct-from-specimen identification of pathogens common in endocarditis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,051,028 | January 4, 2018 | December 31, 2026 | SINGER, ALON | reporter.nih.gov |
| Trypanocidal Agents that Kill Multiple Stages of the Trypanosoma cruzi Life Cycle | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,050,000 | July 20, 2020 | March 31, 2027 | MCDONNELL, MARK E | reporter.nih.gov |
| A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,049,476 | April 1, 2021 | July 31, 2025 | YEH, ROBERT | reporter.nih.gov |
| Quantitative model-based ESUS reclassification using cardiac and cerebral vessel wall MRI | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $3,048,621 | September 21, 2022 | August 31, 2027 | YUAN, CHUN | reporter.nih.gov |
| Neighborhoods and Cardiovascular Risk and Resilience in Rural Communities | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,047,122 | April 1, 2022 | March 31, 2027 | MUJAHID, MAHASIN S | reporter.nih.gov |
| Reducing Arterial Inflammation and Improving Metabolic Health by Dual CCR2 and CCR5 Antagonism in People Living with HIV | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,045,572 | September 5, 2020 | August 31, 2025 | LO, JANET | reporter.nih.gov |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK AREA A - CORE OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,040,735 | December 19, 2024 | April 11, 2025 | BERTONI, ALAIN GERALD | reporter.nih.gov |
| The PREVENTABLE Physical Performance Ancillary Study | NIH | National Institute on Aging | 2021 to 2024 | $3,040,350 | September 30, 2021 | May 31, 2028 | HOUSTON, DENISE KATHRYN | reporter.nih.gov |
| Early Detection of Transthyretin Cardiac Amyloidosis: Defining a Novel Target for HFpEF Treatment and Prevention in Late Life | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,039,615 | March 1, 2020 | January 31, 2026 | DORBALA, SHARMILA | reporter.nih.gov |
| The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,039,522 | December 1, 2021 | November 30, 2026 | CHEN, HONG | reporter.nih.gov |
| (1/2) Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,039,242 | August 1, 2021 | July 31, 2026 | MCNAMARA, DENNIS M. | reporter.nih.gov |
| Targeting the Active Resolution of Inflammation for Cardiovascular Disease Prevention | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,038,765 | December 1, 2021 | November 30, 2026 | MORA, SAMIA | reporter.nih.gov |
| Platelet Integrin AlphaIIbBeta3 Structure, Activation, and Ligand Binding: Fibrinogen, Fibrin, D-dimer, and von Willebrand Factor | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,038,586 | September 1, 1976 | May 5, 2026 | COLLER, BARRY | reporter.nih.gov |
| Acute Antibody Mediated Kidney Allograft Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,037,635 | September 17, 2021 | August 31, 2026 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| The emerging role of apelin, RAAS, and ACE2 crosstalk in pulmonary hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,037,281 | August 1, 2022 | July 31, 2027 | FRUMP, ANDREA LEE | reporter.nih.gov |
| Using genetics to discover mechanisms of abdominal aortic aneurysm | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,035,645 | August 18, 2011 | May 31, 2028 | CHEN, YUQING EUGENE | reporter.nih.gov |
| Cardiovascular Health of Low-Income Working-Age Adults in the US: Health Care Access, Policy, and the Pandemic | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,033,771 | July 1, 2022 | June 30, 2027 | WADHERA, RISHI KUMAR | reporter.nih.gov |
| Enhancing parasympathetic activity to reduce vascular oxidative stress and endothelial dysfunction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,026,236 | June 1, 2021 | May 31, 2026 | SHIBAO, CYNDYA ADRIANA | reporter.nih.gov |
| Mitochondrial respiration as a regulator of lymphatic cell fate and therapeutic lymphangiogenesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,026,108 | July 1, 2022 | June 30, 2027 | OLIVER, GUILLERMO C | reporter.nih.gov |
| Early cardiac progenitors | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,025,531 | July 1, 2013 | July 31, 2029 | BRUNEAU, BENOIT GAETAN | reporter.nih.gov |
| Heightened hypoxia and DNA methylation in heart defects of diabetic embryopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,020,733 | September 15, 2022 | July 31, 2027 | YANG, PEIXIN | reporter.nih.gov |
| Targeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,020,183 | April 1, 2018 | March 31, 2025 | CHAUHAN, ANIL KUMAR | reporter.nih.gov |
| Interacting mechanisms of sleep and aerobic fitness: Implications for health in the growing child | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,019,150 | April 15, 2021 | March 31, 2026 | NEIKRUG, ARIEL BOAZ | reporter.nih.gov |
| The identification and pathophysiology of non-infarcted but injured myocardium in the post-ischemic heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,015,015 | January 1, 2021 | December 31, 2025 | ZHAO, MING | reporter.nih.gov |
| The Identification and characterization of genetic variants underlying cardiovascular diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,015,000 | January 23, 2017 | December 31, 2023 | MANI, ARYA | reporter.nih.gov |
| The novel role of beta3 integrin in regulating alloimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,014,928 | February 14, 2022 | January 31, 2027 | ABDI, REZA | reporter.nih.gov |
| Prospective Investigation of Palliative and End-of-Life ExpeRiences with ICDs (PIPER-ICD) Study | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,011,582 | July 15, 2022 | June 30, 2027 | KRAMER, DANIEL BRUCE | reporter.nih.gov |
| Genome-wide association study of coronary artery disease in individuals of African ancestry | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,009,772 | August 1, 2021 | July 31, 2025 | LU, YINGCHANG | reporter.nih.gov |
| Cell-Type Specific Mechanisms of Mitral Valve Prolapse | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,008,247 | September 1, 2025 | August 31, 2029 | CHI, NEIL C | reporter.nih.gov |
| Effect of reproductive history on longitudinal change in cardiac, vascular and lipid parameters | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,007,759 | December 1, 2021 | November 30, 2026 | WOO, JESSICA G | reporter.nih.gov |
| Characterization of an isoform specific anticoagulant function of TFPI-alpha | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,004,684 | August 1, 2002 | June 30, 2028 | MAST, ALAN E | reporter.nih.gov |
| Prolonged Normothermic Ex vivo Heart Perfusion (NEVHP) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,004,032 | September 1, 2022 | June 30, 2026 | ROJAS-PENA, ALVARO | reporter.nih.gov |
| Assessing Syndemics of Cardiovascular Disease in People with and without HIV | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,003,333 | August 15, 2022 | June 30, 2027 | SILVERBERG, MICHAEL J | reporter.nih.gov |
| Whole-genome sequencing analysis of coronary atherosclerosis and related traits | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,003,154 | March 17, 2020 | February 28, 2026 | DE VRIES, PAUL STEFAN | reporter.nih.gov |
| Development of a Dual-Targeting ClpP Activating Antibiotic | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,999,619 | September 1, 2023 | August 31, 2026 | LAFLEUR, MICHAEL | reporter.nih.gov |
| In vivo Characterization of Regulatory Variant Pathogenicity in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,998,900 | January 1, 2022 | December 31, 2026 | VISEL, AXEL | reporter.nih.gov |
| Vaccine Induced Immune-Inflammatory Response and Cardiovascular Risk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,998,175 | April 1, 2021 | March 31, 2026 | CHENG, SUSAN | reporter.nih.gov |
| Commercialization Readiness Pilot (CRP) program support for: Direct-from-specimen identification of pathogens common in endocarditis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,997,234 | June 20, 2023 | May 31, 2027 | SINGER, ALON | reporter.nih.gov |
| New generation of catheters for treatment of atrial fibrillation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,995,944 | July 14, 2014 | October 31, 2026 | RANSBURY, TERRY | reporter.nih.gov |
| Molecular Mechanisms Governing Vascular Cell Function and Phenotype in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,993,449 | April 1, 2021 | March 31, 2026 | CHEN, HONG | reporter.nih.gov |
| Clinical translation of targeted intracoronary imaging for inflammatory activity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,992,135 | July 22, 2022 | June 30, 2027 | TEARNEY, GUILLERMO J | reporter.nih.gov |
| BiVACOR - A Physiological, Durable and Blood-Friendly Total Artificial Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,992,071 | September 1, 2017 | April 30, 2024 | TIMMS, DANIEL | reporter.nih.gov |
| Eliminating Ventricular Tachycardia: Pivotal Clinical Trial using the Durablate® Catheter | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,990,754 | September 12, 2023 | August 31, 2026 | CURLEY, MICHAEL G | reporter.nih.gov |
| Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,986,551 | August 1, 2017 | August 31, 2027 | WINGER, JONATHAN A | reporter.nih.gov |
| Impact of Asymptomatic CMV on Cardiovascular Event Risk in Treated HIV | NIH | National Heart, Lung, and Blood Institute | 2025 | $2,981,544 | August 15, 2025 | July 31, 2029 | HUNT, PETER W | reporter.nih.gov |
| EOI::DEFEND THE SPEND::EOI NOTICE OF TERMINATION FOR CONVENIENCE | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,981,331 | December 19, 2024 | April 11, 2025 | SHEA, STEVEN J | reporter.nih.gov |
| Super Resolution Ultrasound Imaging of Vasa Vasorum to Characterize the Progression of Atherosclerotic Plaques and Predict Rupture Vulnerability | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,981,035 | February 1, 2022 | January 31, 2027 | KIM, KANG | reporter.nih.gov |
| Defining Genetic Architecture and Pathways of DCM | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,976,096 | April 1, 2005 | January 31, 2026 | SEIDMAN, JONATHAN G | reporter.nih.gov |
| Cardiac MR-Based Risk Stratification for Heart Failure and Atrial Fibrillation in HCM | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,975,089 | April 15, 2021 | March 31, 2026 | NEZAFAT, REZA | reporter.nih.gov |
| Machine Learning in Atrial Fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,973,126 | April 1, 2020 | March 31, 2026 | NARAYAN, SANJIV M | reporter.nih.gov |
| Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,970,040 | July 1, 2022 | June 30, 2027 | FAIRWEATHER, DELISA | reporter.nih.gov |
| Intersection of Obesity and Heart Failure with Preserved Ejection Fraction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,969,927 | July 20, 2023 | December 31, 2029 | KASS, DAVID ALAN | reporter.nih.gov |
| Human on a chip systems to investigate disease comorbidities common in the aged population | NIH | National Institute on Aging | 2021 to 2022 | $2,967,932 | April 1, 2018 | April 30, 2025 | SHULER, MICHAEL L | reporter.nih.gov |
| Elucidating the role of the gut reservoir and inflammation in driving cardiovascular disease among persons living with HIV | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,964,765 | July 22, 2022 | June 30, 2027 | LAHIRI, CECILE DELILLE | reporter.nih.gov |
| Effectiveness and Safety of Transcatheter Left Atrial Appendage Occlusion vs. Anticoagulation in Older Adults with Atrial Fibrillation and Alzheimer's Disease and Related dementias | NIH | National Institute on Aging | 2022 to 2025 | $2,962,676 | August 1, 2022 | April 30, 2027 | LIN, JOSHUA K | reporter.nih.gov |
| Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,960,871 | April 1, 2016 | February 28, 2026 | CHENG, SUSAN | reporter.nih.gov |
| Dietary Etiologies of Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,960,284 | December 1, 1985 | May 19, 2025 | RIMM, ERIC B | reporter.nih.gov |
| Sudden Death Risk Assessment and Mechanistic Insights in Arrhythmic Mitral Valve Prolapse Using Cardiac MRI and Circulating Proteomic Biomarkers | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,960,139 | September 5, 2024 | June 30, 2029 | SHAH, DIPAN J. | reporter.nih.gov |
| Coordinating Center for the DECIPHeR Network | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,959,870 | September 10, 2020 | August 31, 2027 | STEVENS, JUNE | reporter.nih.gov |
| Multiparametric MRI for the investigation of coronary microvascular disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,958,179 | May 12, 2022 | April 30, 2027 | EPSTEIN, FREDERICK H | reporter.nih.gov |
| Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,954,136 | July 1, 2022 | June 30, 2027 | OETJENS, MATTHEW | reporter.nih.gov |
| Neural and Molecular Mechanisms Underlying Stress-Induced Inflammatory Responses | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,953,265 | May 1, 2021 | April 30, 2027 | MUSCATELL, KEELY ANN | reporter.nih.gov |
| Improving Diabetic Patients’ Adherence to Treatment and Prevention of Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,952,168 | July 15, 2020 | April 30, 2026 | OLOMU, ADESUWA B | reporter.nih.gov |
| Early life household air pollution, metal composition and cardiovascular health: Evidence from GRAPHS | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $2,950,170 | September 7, 2022 | June 30, 2027 | LEE, ALISON G | reporter.nih.gov |
| Arrhythmia mapping using electromechanical wave imaging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,947,262 | December 15, 2017 | February 29, 2028 | KONOFAGOU, ELISA E. | reporter.nih.gov |
| Whole genome sequences in ethnically diverse individuals to comprehensively characterize the genetic mechanisms of dyslipidemias | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,945,022 | May 1, 2019 | July 31, 2028 | NATARAJAN, PRADEEP | reporter.nih.gov |
| Cardiothoracic Surgical Trials Network Linked Clinical Research Centers for Virginia and West Virginia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,943,987 | July 1, 2007 | February 28, 2027 | YARBORO, LEORA | reporter.nih.gov |
| Mechanistic Risk Prediction of Radiation Therapy Cardiotoxicity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,943,376 | July 15, 2020 | June 30, 2026 | KY, BONNIE | reporter.nih.gov |
| Polyunsaturated fatty acids as anti-arrhythmic agents. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,942,029 | September 15, 2016 | March 31, 2026 | BARRO-SORIA, RENE | reporter.nih.gov |
| Genetics and Molecular Biology of Striated Muscle Myosin | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,940,688 | July 1, 1983 | April 30, 2027 | BERNSTEIN, SANFORD I | reporter.nih.gov |
| Endothelial Rap1 in the control of heart function | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,940,444 | January 19, 2022 | December 31, 2026 | CHRZANOWSKA, MAGDALENA | reporter.nih.gov |
| Mechanisms of diuretic resistance in heart failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,937,826 | June 1, 2022 | May 31, 2027 | TESTANI, JEFFREY M | reporter.nih.gov |
| Novel Role of Interleukin-17 in Sympathetic Activation in Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,936,014 | January 8, 2021 | December 31, 2026 | WEI, SHUNGUANG | reporter.nih.gov |
| Xenon MRI in Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,935,947 | June 1, 2021 | May 31, 2026 | RAJAGOPAL, SUDARSHAN K | reporter.nih.gov |
| RADIOMIC APPROACHES TO IMPROVE TARGETING FOR ATRIAL FIBRILLATION CATHETER ABLATION | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,935,937 | July 15, 2021 | June 30, 2025 | CHUNG, MINA KAY | reporter.nih.gov |
| Immunologic, Inflammatory, and Clinical contributors to HIV-Related Heart Failure with Preserved Ejection Fraction (HFpEF) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,935,277 | February 25, 2021 | January 31, 2026 | FEINSTEIN, MATTHEW JOEL | reporter.nih.gov |
| Mechanistic Basis of Cardiac Laminopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,934,243 | September 16, 2021 | June 30, 2026 | WORMAN, HOWARD J | reporter.nih.gov |
| Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors | NIH | National Cancer Institute | 2022 to 2025 | $2,933,453 | July 15, 2022 | April 30, 2027 | HOWELL, REBECCA MAUREEN | reporter.nih.gov |
| Increasing Ischemic Myocardial Tissue Perfusion by Mechanical LV Support | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,933,083 | December 15, 2017 | November 30, 2026 | ISHIKAWA, KIYOTAKE | reporter.nih.gov |
| Immune Mechanisms Regulating Cardiac Remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,929,813 | February 1, 2021 | January 31, 2026 | VAN BERLO, JOHANNES (JOP) | reporter.nih.gov |
| Infusible Extracellular Matrix for Treating Myocardial Infarction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,929,153 | June 10, 2022 | May 31, 2027 | CHRISTMAN, KAREN L | reporter.nih.gov |
| Cardiothoracic Surgical Trials Network | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,925,675 | July 1, 2007 | February 28, 2027 | GILLINOV, ALAN MARC | reporter.nih.gov |
| Cardiac resident macrophages in AV node conduction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,919,828 | December 1, 2021 | November 30, 2026 | HULSMANS, MAARTEN | reporter.nih.gov |
| Biological substrate modification to suppress ventricular arrhythmias in a porcine model of chronic ischemic cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,915,879 | September 1, 2022 | August 31, 2027 | DAWKINS, JAMES F. | reporter.nih.gov |
| 2/2 REPRIEVE Extension for Trial Completion | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,915,073 | May 1, 2023 | April 30, 2027 | LU, MICHAEL TSE-YIN | reporter.nih.gov |
| Murine cardiac vector-flow imaging with high-frequency 2D row-column CMUT arrays | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,915,054 | September 1, 2022 | August 31, 2026 | KETTERLING, JEFFREY | reporter.nih.gov |
| Using Electrocardiogram Genetics to Inform Arrhythmia Risk | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,913,758 | January 20, 2022 | December 31, 2026 | ELLINOR, PATRICK THOMAS | reporter.nih.gov |
| Neurometabolic Outcomes of Different Cardiopulmonary Bypass Strategies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,911,403 | February 15, 2021 | January 31, 2026 | HANLEY, FRANK | reporter.nih.gov |
| Role of Skeletal Muscle in Pulmonary Vascular Remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,909,455 | August 15, 2018 | June 30, 2028 | LAI, YEN CHUN CHARLY | reporter.nih.gov |
| NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,907,004 | July 1, 2020 | June 30, 2026 | POYAN MEHR, ALI | reporter.nih.gov |
| Imaging and Targeting Lung Proteolysis in ARDS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,905,205 | August 26, 2021 | July 31, 2025 | SINUSAS, ALBERT J | reporter.nih.gov |
| Myosin Gene Diversity and Function | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,903,288 | September 1, 1981 | May 31, 2028 | LEINWAND, LESLIE ANNE | reporter.nih.gov |
| Novel lead compound advancement for mitigating halogen-induced mortality and morbidity. | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $2,901,967 | September 16, 2022 | June 30, 2027 | AHMAD, SHAMA | reporter.nih.gov |
| Polypill strategy for the evidence-based management of heart failure with reduced ejection fraction in an underserved patient population | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,900,730 | May 14, 2022 | January 31, 2026 | PANDEY, AMBARISH | reporter.nih.gov |
| Role of Metabolic Reprogramming in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,900,593 | July 1, 2021 | June 30, 2025 | OWENS, GARY K | reporter.nih.gov |
| Incorporation of a Hypertension Working Group into the Jackson Heart Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,899,917 | July 15, 2013 | June 30, 2025 | LEWIS, CORA E | reporter.nih.gov |
| Pharmacologic Contributors to Patent Ductus Arteriosus | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,898,557 | July 1, 2022 | June 30, 2027 | REESE, JOHN JEFFREY | reporter.nih.gov |
| Stress and Congestive Heart Failure: A mechanistic clinical trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,897,402 | July 1, 2020 | June 30, 2026 | LAMPERT, RACHEL | reporter.nih.gov |
| Mitochondrial ATP Synthase in Cardiac Biology and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,896,074 | June 1, 2022 | May 31, 2027 | KITSIS, RICHARD N | reporter.nih.gov |
| Macrophage heterogeneity in atrial remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,892,041 | September 1, 2021 | July 31, 2027 | HULSMANS, MAARTEN | reporter.nih.gov |
| Probing the Role of Mitochondrial Short-chain Carbon Homeostasis in the Hypertrophied and Failing Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,887,343 | April 1, 2016 | June 30, 2026 | MUOIO, DEBORAH M | reporter.nih.gov |
| Development of a Minimally Invasive Single Cannulation, Compact Single Port Pulsatile Ventricular Assist Device (sppVAD) for Total LV Support | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,886,882 | April 1, 2021 | June 30, 2027 | TOPAZ, STEPHEN R | reporter.nih.gov |
| Circulating Proteomics to Phenotype the Development and Reversal of Myocardial Remodeling in Aortic Stenosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,886,575 | April 1, 2023 | January 31, 2027 | LINDMAN, BRIAN RICHARD | reporter.nih.gov |
| Role of Cyclohexanone Toxicity in Mediating Congenital Cardiac Surgery Outcomes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,885,985 | June 1, 2022 | May 31, 2027 | JANTZIE, LAUREN LEIGH COONEY | reporter.nih.gov |
| Integrating Artificial Intelligence for Optimal Analysis of CardiacPET/CT | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,885,687 | September 22, 2022 | June 30, 2027 | SLOMKA, PIOTR J | reporter.nih.gov |
| A Mobile Relational Agent to Enhance Atrial Fibrillation Self-care | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,884,620 | April 27, 2020 | March 31, 2025 | MAGNANI, JARED W. | reporter.nih.gov |
| Neighborhoods and health across the life course: Early life inequities in food insecurity, diet quality, and chemical exposures | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $2,878,562 | September 1, 2023 | May 31, 2025 | OKEN, EMILY | reporter.nih.gov |
| A tailored exposure intervention targeting exercise anxiety and avoidance in cardiac rehabilitation | NIH | National Institute on Aging | 2021 to 2025 | $2,876,168 | August 15, 2021 | July 31, 2027 | FARRIS, SAMANTHA GWEN | reporter.nih.gov |
| Cardiac Myocyte Protein Partners in Heart Function | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,873,260 | July 18, 2022 | April 30, 2027 | ROSS, ROBERT SCOTT | reporter.nih.gov |
| Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,871,936 | August 1, 2021 | July 31, 2027 | EGBE, ALEXANDER | reporter.nih.gov |
| 1/2 Pediatric Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,870,887 | September 15, 2021 | August 31, 2022 | MOLER, FRANK W | reporter.nih.gov |
| IDENTIFYING SUBCLINICAL TRANSTHYRETIN CARDIAC AMYLOIDOSIS IN ASYMPTOMATIC CARRIERS OF THE V122I TTR ALLELE | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,868,661 | July 1, 2022 | June 30, 2027 | GRODIN, JUSTIN LEE | reporter.nih.gov |
| A protein traffic control system that regulates left-right patterning and heart development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,868,559 | September 1, 2021 | August 31, 2025 | ROHATGI, RAJAT | reporter.nih.gov |
| Sedentary behavior, physical activity, sleep, and cardiovascular risk in pregnancy: the Pregnancy 24/7 cohort study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,868,051 | September 15, 2020 | August 31, 2025 | WHITAKER, KARA MARIE | reporter.nih.gov |
| Computer Modeling of the Tricuspid Valve in Hypoplastic Left Heart Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,867,475 | July 20, 2020 | June 30, 2026 | JOLLEY, MATTHEW | reporter.nih.gov |
| Obstructive sleep apnea, the microbiome and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,867,397 | January 1, 2022 | December 31, 2025 | HADDAD, GABRIEL G | reporter.nih.gov |
| Nitro-Fatty Acids and Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,867,343 | August 1, 2022 | June 30, 2027 | CHEN, YUQING EUGENE | reporter.nih.gov |
| In silico safety pharmacology | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,866,647 | July 5, 2016 | December 31, 2025 | CLANCY, COLLEEN E | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Westat, Inc. | Bethesda, MD | 3 | $370 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 151 | $228.3 million | 0 | $0 |
| Stanford University | Stanford, CA | 177 | $207.7 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 130 | $180.8 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 111 | $176.5 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 113 | $150.7 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 99 | $150.2 million | 0 | $0 |
| University of Washington | Seattle, WA | 110 | $149.7 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 111 | $149.5 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 118 | $145.5 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 81 | $144.7 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 125 | $137.9 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 104 | $133.9 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 100 | $133.6 million | 0 | $0 |
| Ohio State University | Columbus, OH | 114 | $129.2 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 77 | $128 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 72 | $126.6 million | 0 | $0 |
| Duke University | Durham, NC | 102 | $123.8 million | 0 | $0 |
| Emory University | Atlanta, GA | 83 | $122.9 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 97 | $122.6 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 81 | $115.6 million | 0 | $0 |
| Yale University | New Haven, CT | 98 | $115.1 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 72 | $106.4 million | 0 | $0 |
| Washington University | Saint Louis, MO | 96 | $100 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 109 | $96.3 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 55 | $95.9 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 69 | $93.6 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 87 | $93.1 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 65 | $92.7 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 65 | $89.9 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 39 | $87.7 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 49 | $85.3 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 32 | $81.2 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 75 | $80.5 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 78 | $79.7 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 53 | $77.2 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 63 | $64.2 million | 0 | $0 |
| University of California at Davis | Davis, CA | 51 | $63.6 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 48 | $62.8 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 46 | $62.1 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 53 | $60.6 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 39 | $56.4 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 36 | $56 million | 0 | $0 |
| University of Mississippi Med CTR | Jackson, MS | 17 | $53 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 47 | $52 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 29 | $48.3 million | 0 | $0 |
| University of Chicago | Chicago, IL | 39 | $45.4 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 36 | $42.1 million | 0 | $0 |
| University of Nebraska Medical Center | Omaha, NE | 29 | $41.7 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 11 | $41.5 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 30 | $41.3 million | 0 | $0 |
| University of Rochester | Rochester, NY | 35 | $41.1 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 43 | $40.4 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 41 | $39.8 million | 0 | $0 |
| Augusta University | Augusta, GA | 26 | $39.8 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 30 | $38.3 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 30 | $37.4 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 20 | $37.2 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 28 | $36.5 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 38 | $36.2 million | 0 | $0 |
| University of Louisville | Louisville, KY | 34 | $33.3 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 31 | $32.9 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 30 | $32 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 26 | $31.8 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 26 | $31 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 31 | $29.6 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 19 | $29.5 million | 0 | $0 |
| Tufts Medical Center | Boston, MA | 22 | $29.2 million | 0 | $0 |
| University of Florida | Gainesville, FL | 29 | $29.1 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 19 | $28.4 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 22 | $28.2 million | 0 | $0 |
| University of Hawaii | Honolulu, HI | 9 | $28.1 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 34 | $27.5 million | 0 | $0 |
| University of Oklahoma HLTH Sciences CTR | Oklahoma City, OK | 11 | $25.3 million | 0 | $0 |
| Harvard University | Cambridge, MA | 9 | $23.8 million | 0 | $0 |
| J. David Gladstone Institutes | San Francisco, CA | 14 | $23.1 million | 0 | $0 |
| University of South Florida | Tampa, FL | 27 | $23 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 18 | $22.5 million | 0 | $0 |
| Lurie Children's Hospital of Chicago | Chicago, IL | 15 | $22.1 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 15 | $21.4 million | 0 | $0 |
| Wayne State University | Detroit, MI | 15 | $20.6 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 8 | $20.5 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 18 | $20.3 million | 0 | $0 |
| Children's Research Institute | Washington, DC | 19 | $20.1 million | 0 | $0 |
| Research Triangle Institute | Research Triangle Park, NC | 2 | $19.8 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 21 | $19.7 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 16 | $19.7 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 17 | $19.5 million | 0 | $0 |
| New England Research Institutes, Inc. | Wilmington, DE | 3 | $19.3 million | 0 | $0 |
| Loyola University Chicago | Maywood, IL | 17 | $19 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 17 | $19 million | 0 | $0 |
| Brown University | Providence, RI | 20 | $17.5 million | 0 | $0 |
| Fred Hutchinson Cancer Research Center | Seattle, WA | 5 | $17.3 million | 0 | $0 |
| George Washington University | Washington, DC | 18 | $17 million | 0 | $0 |
| University of Vermont & ST Agric College | Burlington, VT | 7 | $16.8 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 25 | $15.9 million | 0 | $0 |
| Northern California Institute/res/edu | San Francisco, CA | 7 | $15.8 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 14 | $15.2 million | 0 | $0 |
| Virginia Polytechnic Institute and State University | Blacksburg, VA | 19 | $15 million | 0 | $0 |
| Rhode Island Hospital | Providence, RI | 15 | $14.7 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 2,724 | $1,656,181,522 | 0 | $0 |
| 2024 | 2,855 | $1,607,738,006 | 0 | $0 |
| 2023 | 2,871 | $1,709,615,926 | 0 | $0 |
| 2022 | 2,890 | $1,615,262,235 | 0 | $0 |
| 2021 | 2,769 | $1,462,107,109 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.